Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,Inverse variance weighted,24,1.11 [1.07-1.16],1.05511879538111e-07,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EFNA1,Ephrin-A1,Inverse variance weighted,11,1.23 [1.12-1.35],7.63134978465278e-06,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL5RA,Interleukin-5 receptor subunit alpha,Inverse variance weighted,18,0.91 [0.86-0.95],9.84211261592888e-05,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ANG,Angiogenin,Inverse variance weighted,19,1.12 [1.05-1.19],0.000415689174825468,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,3,1.47 [1.18-1.83],0.000542403846402706,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LPCAT2,Lysophosphatidylcholine acyltransferase 2,Inverse variance weighted,5,0.77 [0.66-0.9],0.00102242581902565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.17 [1.06-1.29],0.0020015931784061,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD302,CD302 antigen,Inverse variance weighted,9,0.86 [0.78-0.95],0.00214684258788148,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1.15 [1.05-1.27],0.0034028172005329,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.5 [0.31-0.8],0.00367346929484574,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FCRLB,Fc receptor-like B,Inverse variance weighted,61,0.95 [0.91-0.98],0.00388270788598044,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NRP2,Neuropilin-2,Inverse variance weighted,11,0.87 [0.79-0.96],0.0071540158878503,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.27 [1.07-1.51],0.00736926165512708,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,2,0.58 [0.39-0.87],0.00825688568302537,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TYMP,Thymidine phosphorylase,Inverse variance weighted,4,0.83 [0.72-0.96],0.0091265460816329,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.2 [1.04-1.39],0.0111961000480802,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,1.17 [1.03-1.33],0.0157807735660316,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,9,0.79 [0.65-0.96],0.0164768244636504,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.13 [1.02-1.25],0.0173871084582851,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,0.91 [0.84-0.98],0.0187727229883468,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,0.9 [0.83-0.98],0.0192470177356513,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,0.77 [0.62-0.96],0.021496609630097,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,1.07 [1.01-1.13],0.0223816962895217,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ABL1,Tyrosine-protein kinase ABL1,Wald ratio,1,1.66 [1.07-2.56],0.023490383351346,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CAPG,Macrophage-capping protein,Inverse variance weighted,33,0.94 [0.88-0.99],0.026485490749463,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KLKB1,Plasma kallikrein,Inverse variance weighted,15,0.93 [0.87-0.99],0.0284719743986831,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,1.28 [1.03-1.6],0.0289007936869892,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EGLN1,Egl nine homolog 1,Inverse variance weighted,3,1.25 [1.02-1.54],0.0290462641626043,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NID1,Nidogen-1,Inverse variance weighted,6,0.89 [0.8-0.99],0.0294965380309766,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,15,0.91 [0.83-0.99],0.0298621741600474,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PRG2,Bone marrow proteoglycan,Wald ratio,1,1.51 [1.04-2.21],0.0319147038857593,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,THBD,Thrombomodulin,Inverse variance weighted,5,1.17 [1.01-1.34],0.0346209823179007,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.95 [0.91-1],0.0358827424974765,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.15 [1.01-1.3],0.037341822530059,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,12,0.92 [0.85-1],0.0376558568736269,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CHGB,Secretogranin-1,Inverse variance weighted,27,0.95 [0.9-1],0.0383245498184095,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,Wald ratio,1,0.69 [0.48-0.98],0.0386656788187891,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GFER,FAD-linked sulfhydryl oxidase ALR,Wald ratio,1,1.49 [1.02-2.17],0.0392429367624905,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CNTNAP2,Contactin-associated protein-like 2,Inverse variance weighted,31,0.94 [0.89-1],0.0398287518776417,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FABP5,Fatty acid-binding protein 5,Wald ratio,1,1.24 [1.01-1.53],0.0410918645823935,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,0.94 [0.89-1],0.0419874337166737,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FGA,Fibrinogen alpha chain,Inverse variance weighted,7,0.84 [0.7-1],0.0459056965379144,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.84 [0.7-1],0.0494447279492398,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PRND,Prion-like protein doppel,Inverse variance weighted,9,0.93 [0.86-1],0.0499623092296152,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LGMN,Legumain,Inverse variance weighted,12,0.93 [0.86-1],0.050615692224265,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,2.22 [1-4.95],0.0507529584975634,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SPP1,Osteopontin,Inverse variance weighted,8,0.8 [0.64-1],0.0522645216216315,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,3,0.83 [0.68-1],0.0523867150891656,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TCN2,Transcobalamin-2,Inverse variance weighted,34,1.05 [1-1.1],0.0527255954015726,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,Inverse variance weighted,13,0.93 [0.86-1],0.0534538137450287,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PYY,Peptide YY,Inverse variance weighted,6,0.89 [0.8-1],0.0561245189119001,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DSG3,Desmoglein-3,Inverse variance weighted,7,1.12 [1-1.25],0.0581688188007466,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CTSD,Cathepsin D,Inverse variance weighted,17,1.08 [1-1.17],0.0590858227812734,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1.07 [1-1.16],0.0608848245822857,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NXPH3,Neurexophilin-3,Inverse variance weighted,11,1.09 [1-1.19],0.0609608398551781,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BOLA1,BolA-like protein 1,Wald ratio,1,1.37 [0.99-1.89],0.0615150805905598,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,10,1.09 [1-1.2],0.0617987281954038,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,1.14 [0.99-1.31],0.0638969371027846,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,0.88 [0.78-1.01],0.0654927333493297,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,19,0.92 [0.84-1.01],0.0679006847634933,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,0.86 [0.74-1.01],0.0682015502260638,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,Inverse variance weighted,3,0.88 [0.77-1.01],0.0692218749340908,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.29 [0.98-1.7],0.0692995804385488,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LMNB2,Lamin-B2,Wald ratio,1,0.51 [0.25-1.06],0.0702316635188088,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,1.13 [0.99-1.3],0.0709361496997322,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,1.34 [0.97-1.83],0.0716511436146061,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,3,1.35 [0.97-1.88],0.0728688046005557,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,1.04 [1-1.08],0.0740533958740659,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,16,0.93 [0.86-1.01],0.0762152851700525,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ANPEP,Aminopeptidase N,Inverse variance weighted,23,1.06 [0.99-1.14],0.076331525039363,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CST7,Cystatin-F,Inverse variance weighted,39,0.96 [0.92-1],0.0778857058063556,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,0.93 [0.85-1.01],0.0783110383999176,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,XCL1,Lymphotactin,Inverse variance weighted,31,0.96 [0.92-1],0.0788804462304511,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,APOA2,Apolipoprotein A-II,Wald ratio,1,0.67 [0.43-1.05],0.0792043726588091,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PRSS27,Serine protease 27,Inverse variance weighted,5,0.91 [0.82-1.01],0.0816121062367648,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CHAD,Chondroadherin,Inverse variance weighted,3,1.08 [0.99-1.18],0.0823790606301664,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RGMB,RGM domain family member B,Inverse variance weighted,9,0.86 [0.72-1.02],0.0824158511381576,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,0.96 [0.91-1.01],0.0843297550404324,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SEMA7A,Semaphorin-7A,Inverse variance weighted,5,0.84 [0.69-1.02],0.0847779502823279,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.77 [0.57-1.04],0.0861450707791892,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,1.19 [0.98-1.45],0.0867375403783288,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PRTN3,Myeloblastin,Inverse variance weighted,21,0.93 [0.87-1.01],0.0871948567679304,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GRP,Gastrin-releasing peptide,Inverse variance weighted,12,1.05 [0.99-1.12],0.0872806407522914,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,0.74 [0.52-1.05],0.0894809718298014,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GPC5,Glypican-5,Inverse variance weighted,33,0.96 [0.91-1.01],0.0910965419794691,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL27,C-C motif chemokine 27,Inverse variance weighted,4,1.11 [0.98-1.25],0.0925750028733767,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TFF1,Trefoil factor 1,Inverse variance weighted,8,1.12 [0.98-1.27],0.0968173806167435,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.11 [0.98-1.27],0.0985255998297656,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,0.92 [0.84-1.02],0.100594416978316,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CTSH,Pro-cathepsin H,Inverse variance weighted,33,1.03 [0.99-1.07],0.100679863528747,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PLIN3,Perilipin-3,Wald ratio,1,1.4 [0.94-2.1],0.101393693832139,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.5 [0.92-2.42],0.101690689192654,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,1.08 [0.98-1.19],0.105533625339441,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD34,Hematopoietic progenitor cell antigen CD34,Wald ratio,1,0.66 [0.4-1.09],0.105784846015962,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EPPK1,Epiplakin,Inverse variance weighted,33,1.04 [0.99-1.08],0.107380833766047,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1.09 [0.98-1.21],0.108736724020023,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD55,Complement decay-accelerating factor,Inverse variance weighted,15,0.95 [0.89-1.01],0.109160478311022,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,0.87 [0.73-1.03],0.110272703415676,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TPR,Nucleoprotein TPR,Wald ratio,1,1.45 [0.92-2.28],0.110768692939203,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,Inverse variance weighted,17,0.94 [0.87-1.01],0.111474961183909,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,1.05 [0.99-1.12],0.111511508428484,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,3,1.25 [0.95-1.65],0.112207581153959,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SUOX,"Sulfite oxidase, mitochondrial",Inverse variance weighted,3,1.76 [0.87-3.56],0.114782018172503,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.09 [0.98-1.22],0.117268835026892,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GUCA2A,Guanylin,Inverse variance weighted,9,0.9 [0.79-1.03],0.117735369693296,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,0.95 [0.89-1.01],0.119035565942533,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IFNL1,Interferon lambda-1,Wald ratio,1,0.59 [0.3-1.15],0.119771795785656,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,14,1.06 [0.98-1.14],0.122475103880109,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,1.06 [0.99-1.13],0.122680139673707,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NPTX2,Neuronal pentraxin-2,Inverse variance weighted,17,1.11 [0.97-1.27],0.125745574512819,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SCLY,Selenocysteine lyase,Inverse variance weighted,4,0.9 [0.78-1.03],0.125820869526703,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SERPINB8,Serpin B8,Inverse variance weighted,28,0.97 [0.94-1.01],0.125888336128831,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,1.17 [0.96-1.43],0.125995499300172,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1.11 [0.97-1.28],0.126737192483434,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FGFBP2,Fibroblast growth factor-binding protein 2,Inverse variance weighted,21,1.05 [0.99-1.11],0.127158191123872,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,0.96 [0.91-1.01],0.127324855924397,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,13,0.93 [0.86-1.02],0.1276609187499,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.87 [0.73-1.04],0.128144806909026,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,26,0.94 [0.86-1.02],0.128936986387427,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RTBDN,Retbindin,Inverse variance weighted,3,0.88 [0.75-1.04],0.13010019492271,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,1.22 [0.94-1.57],0.130207729783929,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,1.17 [0.95-1.43],0.130224987574205,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,19,0.96 [0.92-1.01],0.130682798573464,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,AMBP,Protein AMBP,Inverse variance weighted,3,1.16 [0.96-1.41],0.13301975835175,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,1.08 [0.98-1.2],0.135268261167576,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,STX8,Syntaxin-8,Wald ratio,1,1.3 [0.92-1.83],0.136475913880294,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.08 [0.97-1.2],0.139511911343451,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,2,0.74 [0.49-1.1],0.139585261856056,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MSMB,Beta-microseminoprotein,Inverse variance weighted,64,0.97 [0.94-1.01],0.139655696556214,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,AGRN,Agrin,Inverse variance weighted,17,0.94 [0.86-1.02],0.14018534037523,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,P4HB,Protein disulfide-isomerase,Inverse variance weighted,2,0.71 [0.45-1.12],0.141969352494378,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,17,0.97 [0.94-1.01],0.142269510208987,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SPON2,Spondin-2,Inverse variance weighted,4,1.12 [0.96-1.31],0.142708404299255,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,1.49 [0.87-2.56],0.142845510297328,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,0.96 [0.91-1.01],0.142847837704163,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,0.94 [0.87-1.02],0.144508628746014,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,0.82 [0.62-1.07],0.144548166628771,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,1.05 [0.98-1.13],0.146191577510105,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,STC2,Stanniocalcin-2,Inverse variance weighted,3,0.79 [0.57-1.09],0.146610602983723,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,USP28,Ubiquitin carboxyl-terminal hydrolase 28,Inverse variance weighted,2,0.79 [0.57-1.09],0.149538158410916,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,20,1.03 [0.99-1.08],0.149857593899638,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SELENOP,Selenoprotein P,Inverse variance weighted,2,0.83 [0.65-1.07],0.150502720135134,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.04 [0.99-1.1],0.151438220464075,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,0.96 [0.9-1.02],0.154555163171858,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCN4,CCN family member 4,Inverse variance weighted,27,0.96 [0.9-1.02],0.154731932385911,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.64 [0.34-1.19],0.158133489997399,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL19,C-C motif chemokine 19,Inverse variance weighted,2,0.82 [0.62-1.08],0.161851199268802,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,13,1.12 [0.96-1.31],0.16335519220754,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GRN,Progranulin,Inverse variance weighted,7,1.07 [0.97-1.17],0.163715674960056,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GLO1,Lactoylglutathione lyase,Inverse variance weighted,13,1.08 [0.97-1.21],0.163862115986874,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,0.88 [0.73-1.06],0.16700192662842,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD48,CD48 antigen,Inverse variance weighted,18,1.03 [0.99-1.08],0.167709155252367,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.12 [0.95-1.31],0.16843280616673,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.78 [0.55-1.11],0.170543029670447,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PSAPL1,Proactivator polypeptide-like 1,Inverse variance weighted,20,0.97 [0.92-1.01],0.170990333835252,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NFASC,Neurofascin,Inverse variance weighted,15,0.95 [0.89-1.02],0.172989947383993,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,0.86 [0.69-1.07],0.174512017358615,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VWC2,Brorin,Inverse variance weighted,22,1.05 [0.98-1.13],0.174517186586927,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PLB1,"Phospholipase B1, membrane-associated",Inverse variance weighted,33,0.97 [0.94-1.01],0.177172056406632,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,21,1.05 [0.98-1.12],0.177600712246801,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RSPO3,R-spondin-3,Inverse variance weighted,6,0.9 [0.77-1.05],0.177983328977943,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DRAXIN,Draxin,Inverse variance weighted,13,0.96 [0.9-1.02],0.179097894703236,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,INSR,Insulin receptor,Wald ratio,1,1.48 [0.83-2.64],0.18240430498682,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MMP8,Neutrophil collagenase,Inverse variance weighted,17,1.04 [0.98-1.1],0.183319835683674,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FAM3B,Protein FAM3B,Inverse variance weighted,18,0.96 [0.91-1.02],0.18347512466485,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RNASE4,Ribonuclease 4,Inverse variance weighted,11,1.06 [0.97-1.15],0.185283787299053,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,5,1.05 [0.98-1.12],0.185531110917019,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,14,1.1 [0.96-1.27],0.185952652894584,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,1.08 [0.96-1.2],0.18822853079336,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL17C,Interleukin-17C,Inverse variance weighted,3,0.87 [0.7-1.07],0.191488828751542,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Inverse variance weighted,18,0.94 [0.86-1.03],0.191860709658134,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1.02 [0.99-1.05],0.191915811709648,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CTSC,Dipeptidyl peptidase 1,Inverse variance weighted,28,0.97 [0.93-1.01],0.194093550154432,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LUZP2,Leucine zipper protein 2,Inverse variance weighted,8,0.92 [0.82-1.04],0.194505921638771,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,COL3A1,Collagen alpha-1(III) chain,Wald ratio,1,1.6 [0.78-3.27],0.196968134738097,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MILR1,Allergin-1,Inverse variance weighted,33,0.98 [0.95-1.01],0.198596322136982,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,8,0.93 [0.83-1.04],0.199016659412131,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,0.92 [0.8-1.05],0.201058411222841,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,10,1.05 [0.97-1.14],0.202228924322029,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,0.93 [0.82-1.04],0.20266230313582,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,21,1.03 [0.99-1.07],0.203520392545396,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FOLR2,Folate receptor beta,Inverse variance weighted,2,1.16 [0.92-1.47],0.20445920281407,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CLSTN2,Calsyntenin-2,Inverse variance weighted,31,0.97 [0.92-1.02],0.204745468306156,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,S100P,Protein S100-P,Inverse variance weighted,2,0.76 [0.49-1.16],0.205073788389445,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,1.06 [0.97-1.15],0.205372753780905,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KLK10,Kallikrein-10,Inverse variance weighted,15,0.95 [0.88-1.03],0.205972544998783,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.69 [0.39-1.22],0.206287135058863,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.96 [0.9-1.02],0.208997410562423,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GHR,Growth hormone receptor,Inverse variance weighted,38,0.98 [0.95-1.01],0.209131523446062,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PSME2,Proteasome activator complex subunit 2,Wald ratio,1,0.82 [0.61-1.12],0.209837839580018,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PRSS2,Trypsin-2,Inverse variance weighted,3,0.89 [0.74-1.07],0.211486820987065,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,1.21 [0.9-1.63],0.211842123274883,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.95 [0.88-1.03],0.216803711465354,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MATN2,Matrilin-2,Inverse variance weighted,18,0.93 [0.84-1.04],0.218746640306268,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,0.94 [0.84-1.04],0.222290237489053,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CA6,Carbonic anhydrase 6,Inverse variance weighted,31,1.04 [0.98-1.1],0.223191044726295,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,2,1.12 [0.93-1.34],0.223696625232046,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SLAMF7,SLAM family member 7,Inverse variance weighted,20,1.03 [0.98-1.08],0.225015219974686,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD46,Membrane cofactor protein,Wald ratio,1,0.82 [0.59-1.13],0.226651212672928,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,1.04 [0.98-1.11],0.226679188338006,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PI3,Elafin,Inverse variance weighted,10,1.05 [0.97-1.15],0.230872395732608,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.88 [0.72-1.08],0.231013144684663,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,14,0.96 [0.91-1.02],0.231565833590361,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,0.93 [0.82-1.05],0.232161095049391,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,0.95 [0.86-1.04],0.236042766840985,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,1.06 [0.96-1.17],0.239272629653384,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,0.91 [0.78-1.06],0.239441363982562,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HEG1,Protein HEG homolog 1,Inverse variance weighted,4,1.16 [0.91-1.49],0.239643428486063,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,22,0.96 [0.9-1.03],0.240947642888109,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PKD1,Polycystin-1,Inverse variance weighted,12,1.06 [0.96-1.17],0.24148599105744,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VGF,Neurosecretory protein VGF,Wald ratio,1,0.62 [0.28-1.38],0.241646984455704,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,0.94 [0.84-1.05],0.243209891793315,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1.03 [0.98-1.09],0.245128056772967,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CTSF,Cathepsin F,Inverse variance weighted,10,0.92 [0.79-1.06],0.245194018295035,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,1.36 [0.81-2.29],0.245691415439735,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.8 [0.54-1.17],0.247785501990726,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",Inverse variance weighted,8,1.09 [0.94-1.25],0.248249105173425,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FASLG,Tumor necrosis factor ligand superfamily member 6,Wald ratio,1,1.29 [0.84-1.98],0.249451994019971,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1.03 [0.98-1.09],0.249714302736021,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,0.94 [0.84-1.05],0.251270496605705,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,0.97 [0.91-1.02],0.251493541007163,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ANXA10,Annexin A10,Wald ratio,1,1.4 [0.79-2.48],0.252474389631636,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PENK,Proenkephalin-A,Inverse variance weighted,19,1.04 [0.97-1.13],0.253691839859664,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DCTPP1,dCTP pyrophosphatase 1,Wald ratio,1,1.46 [0.76-2.82],0.256567139731063,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ENDOU,Poly(U)-specific endoribonuclease,Inverse variance weighted,14,0.95 [0.88-1.04],0.261800258678062,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CLEC3B,Tetranectin,Inverse variance weighted,7,0.92 [0.79-1.07],0.261944627681872,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,0.92 [0.79-1.07],0.263943169717067,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,1.1 [0.93-1.31],0.264643782927221,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,1.17 [0.89-1.53],0.266711680521965,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,4,0.88 [0.69-1.11],0.269153335657396,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.7 [0.37-1.32],0.270467972746462,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1.06 [0.95-1.19],0.276579945118395,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IGFBP1,Insulin-like growth factor-binding protein 1,Wald ratio,1,1.43 [0.75-2.75],0.276590628350267,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PCDH17,Protocadherin-17,Inverse variance weighted,2,1.14 [0.9-1.45],0.276891006568575,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SEPTIN8,Septin-8,Inverse variance weighted,2,1.12 [0.91-1.38],0.277330411251853,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,1.03 [0.98-1.09],0.278603501215964,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,0.95 [0.88-1.04],0.278896157182539,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Inverse variance weighted,39,0.97 [0.91-1.03],0.279011512848967,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Wald ratio,1,1.38 [0.77-2.5],0.280542672557073,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD7,T-cell antigen CD7,Inverse variance weighted,8,1.03 [0.97-1.1],0.282323745056547,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,QSOX1,Sulfhydryl oxidase 1,Inverse variance weighted,24,1.04 [0.97-1.1],0.282437936043632,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,16,1.03 [0.98-1.07],0.28271203105472,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LGALS1,Galectin-1,Inverse variance weighted,6,1.08 [0.94-1.24],0.284780318936765,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,0.65 [0.29-1.44],0.285414273871013,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.22 [0.85-1.75],0.287416906508425,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1.14 [0.89-1.46],0.29173060344617,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,1.1 [0.92-1.33],0.292380123551222,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.95 [0.88-1.04],0.298288307037076,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,0.91 [0.76-1.09],0.300602537567988,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,13,1.05 [0.96-1.16],0.301108772885744,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,0.96 [0.89-1.04],0.30265437788921,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,0.98 [0.93-1.02],0.303123203425867,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,0.87 [0.67-1.13],0.303775033535623,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SEZ6L,Seizure 6-like protein,Inverse variance weighted,8,1.06 [0.95-1.18],0.304876529912178,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DNMBP,Dynamin-binding protein,Inverse variance weighted,5,1.1 [0.92-1.32],0.306686437409199,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,0.96 [0.9-1.04],0.30747988956828,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFSF12,Tumor necrosis factor ligand superfamily member 12,Inverse variance weighted,11,1.05 [0.96-1.14],0.311108866733217,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,17,1.04 [0.96-1.13],0.312017539848603,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,25,1.04 [0.97-1.11],0.313290684477429,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,REN,Renin,Inverse variance weighted,4,1.05 [0.95-1.17],0.313854797505576,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TMPRSS11D,Transmembrane protease serine 11D,Inverse variance weighted,3,0.89 [0.72-1.11],0.314325202019868,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,1.25 [0.81-1.92],0.315292651002202,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,0.97 [0.91-1.03],0.315592488755235,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,14,1.05 [0.96-1.14],0.316270748207093,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,3,1.09 [0.92-1.31],0.318816651949506,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IDUA,Alpha-L-iduronidase,Inverse variance weighted,35,1.02 [0.98-1.07],0.319038825062748,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SERPINA1,Alpha-1-antitrypsin,Inverse variance weighted,4,1.09 [0.92-1.28],0.319095498079581,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,3,0.91 [0.74-1.1],0.319787734426583,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CTSV,Cathepsin L2,Inverse variance weighted,11,0.95 [0.85-1.05],0.32069568012547,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CDH2,Cadherin-2,Inverse variance weighted,3,0.86 [0.64-1.16],0.321825170340693,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,4,1.07 [0.94-1.22],0.321932193042792,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LEPR,Leptin receptor,Inverse variance weighted,8,0.94 [0.84-1.06],0.322479835453544,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CTSS,Cathepsin S,Inverse variance weighted,23,1.03 [0.97-1.1],0.322793746702461,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.06 [0.94-1.19],0.323698059407085,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.94 [0.84-1.06],0.325951985544384,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ITGAM,Integrin alpha-M,Inverse variance weighted,3,0.92 [0.78-1.09],0.326195313181248,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,2,0.87 [0.65-1.15],0.327171384387986,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ACY1,Aminoacylase-1,Inverse variance weighted,4,0.91 [0.75-1.1],0.327709265509756,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MENT,Protein MENT,Inverse variance weighted,3,1.03 [0.97-1.11],0.330385853883937,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.05 [0.95-1.15],0.333650540058633,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VSTM1,V-set and transmembrane domain-containing protein 1,Inverse variance weighted,26,1.02 [0.98-1.06],0.333803662385746,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SCGB3A1,Secretoglobin family 3A member 1,Inverse variance weighted,2,0.9 [0.72-1.12],0.334287018982964,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,2,1.09 [0.92-1.3],0.337260407117331,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1.02 [0.98-1.05],0.338294344196464,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DLL1,Delta-like protein 1,Inverse variance weighted,7,0.93 [0.81-1.07],0.338402925065036,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.02 [0.98-1.06],0.339502747378992,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LGALS3,Galectin-3,Inverse variance weighted,25,0.97 [0.92-1.03],0.339511208307959,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PVR,Poliovirus receptor,Inverse variance weighted,27,1.02 [0.98-1.07],0.340968455775552,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,APOC1,Apolipoprotein C-I,Inverse variance weighted,6,1.15 [0.86-1.53],0.34231925058279,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,0.95 [0.86-1.05],0.343768888291604,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,8,0.95 [0.87-1.05],0.34414971040479,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNR,Tenascin-R,Inverse variance weighted,16,1.03 [0.96-1.11],0.346509742615529,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ICAM3,Intercellular adhesion molecule 3,Inverse variance weighted,10,1.06 [0.94-1.21],0.350856748997651,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,55,0.99 [0.96-1.01],0.352804083756809,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ATOX1,Copper transport protein ATOX1,Wald ratio,1,1.21 [0.81-1.83],0.35323380032535,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,Inverse variance weighted,32,1.02 [0.98-1.07],0.353512292420925,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL10,Interleukin-10,Wald ratio,1,0.87 [0.66-1.16],0.353590734211471,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,0.96 [0.88-1.05],0.355400275112569,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GSN,Gelsolin,Inverse variance weighted,5,1.11 [0.88-1.41],0.356584952501934,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,OGN,Mimecan,Inverse variance weighted,30,1.03 [0.97-1.09],0.358069075819062,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BAP18,Chromatin complexes subunit BAP18,Wald ratio,1,1.19 [0.82-1.72],0.358594522865776,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SPARCL1,SPARC-like protein 1,Inverse variance weighted,35,1.02 [0.98-1.07],0.358887774685013,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CPM,Carboxypeptidase M,Inverse variance weighted,4,1.1 [0.9-1.35],0.359389964817716,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,AREG,Amphiregulin,Inverse variance weighted,3,0.92 [0.76-1.11],0.359886248071998,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.12 [0.88-1.43],0.360239297106587,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL19,Interleukin-19,Inverse variance weighted,11,0.96 [0.88-1.05],0.361821122306347,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1.06 [0.93-1.21],0.362823542339127,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,9,0.95 [0.85-1.06],0.366353510550047,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,AGRP,Agouti-related protein,Inverse variance weighted,3,0.87 [0.64-1.18],0.367740538738056,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LGALS4,Galectin-4,Inverse variance weighted,4,0.92 [0.77-1.1],0.369226622721507,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,0.95 [0.85-1.06],0.369971125122591,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CSTB,Cystatin-B,Inverse variance weighted,28,1.03 [0.96-1.1],0.370300049509556,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.02 [0.98-1.05],0.372514834594806,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,2,0.71 [0.34-1.5],0.372955545143068,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.03 [0.96-1.1],0.379986363329428,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VASN,Vasorin,Inverse variance weighted,14,0.97 [0.91-1.04],0.381044395985461,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PCDHB15,Protocadherin beta-15,Inverse variance weighted,29,0.98 [0.93-1.03],0.384385823018472,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,Inverse variance weighted,3,0.91 [0.73-1.13],0.3857665014923,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CPA4,Carboxypeptidase A4,Inverse variance weighted,21,1.02 [0.97-1.08],0.386988827324279,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CTSO,Cathepsin O,Inverse variance weighted,6,1.06 [0.92-1.22],0.387366989908088,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HSPB6,Heat shock protein beta-6,Wald ratio,1,1.38 [0.66-2.87],0.389548655963584,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,27,0.98 [0.94-1.02],0.389935984677449,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MB,Myoglobin,Wald ratio,1,1.41 [0.65-3.06],0.390526380196791,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,34,1.02 [0.98-1.06],0.391403027875775,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,JAM3,Junctional adhesion molecule C,Inverse variance weighted,4,1.1 [0.89-1.36],0.391691287421382,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,31,1.02 [0.98-1.05],0.392709701121921,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SLAMF8,SLAM family member 8,Inverse variance weighted,25,1.01 [0.98-1.05],0.395101212064416,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,7,1.09 [0.9-1.31],0.395283275741062,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ROBO1,Roundabout homolog 1,Inverse variance weighted,10,1.06 [0.92-1.23],0.395799014397438,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,OGFR,Opioid growth factor receptor,Inverse variance weighted,2,1.16 [0.82-1.65],0.397594605522177,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KIF1C,Kinesin-like protein KIF1C,Wald ratio,1,1.45 [0.61-3.41],0.398574351389851,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL18,C-C motif chemokine 18,Inverse variance weighted,15,1.02 [0.97-1.08],0.399014882350048,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,0.97 [0.89-1.05],0.399787961798692,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,1.17 [0.82-1.67],0.40022162212059,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,1.02 [0.97-1.08],0.401152180052384,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RBP7,Retinoid-binding protein 7,Inverse variance weighted,8,1.08 [0.9-1.28],0.403847446652016,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,0.95 [0.83-1.08],0.406031925512119,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PALM,Paralemmin-1,Inverse variance weighted,6,1.06 [0.92-1.23],0.406569988823988,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.95 [0.83-1.08],0.407059017077058,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,UMOD,Uromodulin,Inverse variance weighted,29,1.02 [0.98-1.05],0.41114031872929,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NUDT5,ADP-sugar pyrophosphatase,Wald ratio,1,0.81 [0.49-1.34],0.411485808962512,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.04 [0.94-1.15],0.411489008786526,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,0.83 [0.52-1.3],0.413119481871764,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,0.97 [0.91-1.04],0.413693824447811,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,Wald ratio,1,1.19 [0.78-1.79],0.417345484736834,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Inverse variance weighted,4,0.95 [0.85-1.07],0.417550993583077,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,0.93 [0.78-1.11],0.418896995219973,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL22,C-C motif chemokine 22,Inverse variance weighted,6,1.08 [0.9-1.28],0.420665993253757,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD160,CD160 antigen,Inverse variance weighted,11,0.97 [0.9-1.04],0.422375091001012,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Wald ratio,1,0.87 [0.61-1.23],0.424873935968218,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,1.06 [0.92-1.22],0.427279864084291,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,1.2 [0.76-1.9],0.430488088182725,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,1.41 [0.6-3.28],0.430833415926898,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.05 [0.94-1.17],0.431932381221835,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,0.95 [0.83-1.08],0.432104403528179,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PCDH7,Protocadherin-7,Inverse variance weighted,3,1.14 [0.82-1.58],0.432140246960095,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,5,0.91 [0.72-1.15],0.432279175807684,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL4,C-C motif chemokine 4,Inverse variance weighted,18,0.97 [0.89-1.05],0.43314275615939,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,14,0.94 [0.79-1.11],0.436299191052569,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,Wald ratio,1,1.15 [0.81-1.61],0.437592090752612,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.91 [0.73-1.15],0.440725210429592,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,22,1.02 [0.97-1.08],0.441129675624286,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.02 [0.96-1.09],0.442369671545157,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.03 [0.96-1.1],0.443940035908881,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,Inverse variance weighted,26,0.98 [0.93-1.03],0.444746056617261,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.11 [0.85-1.44],0.446414996612359,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SUSD4,Sushi domain-containing protein 4,Inverse variance weighted,15,0.96 [0.87-1.06],0.448206928358612,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KIAA0319,Dyslexia-associated protein KIAA0319,Inverse variance weighted,14,1.02 [0.96-1.09],0.449257712698367,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,16,0.97 [0.89-1.05],0.451968075723467,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,11,0.97 [0.9-1.05],0.452232337870709,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,Inverse variance weighted,19,0.98 [0.94-1.03],0.45403333715655,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SLAMF6,SLAM family member 6,Inverse variance weighted,2,0.94 [0.81-1.1],0.454147324072117,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ITGAV,Integrin alpha-V,Inverse variance weighted,5,1.08 [0.88-1.33],0.45471942215292,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PLXNB2,Plexin-B2,Inverse variance weighted,27,0.99 [0.95-1.02],0.454901433664617,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,0.96 [0.87-1.06],0.457395445034233,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,6,0.98 [0.94-1.03],0.458365263061555,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",Wald ratio,1,0.83 [0.52-1.35],0.458645571232082,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,0.94 [0.8-1.1],0.458844629958271,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,19,0.98 [0.93-1.03],0.45999671719593,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,0.98 [0.94-1.03],0.460840602923585,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,S100A11,Protein S100-A11,Wald ratio,1,1.08 [0.88-1.32],0.462381304280655,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,F11R,Junctional adhesion molecule A,Wald ratio,1,0.84 [0.52-1.35],0.464202488471072,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,0.9 [0.67-1.2],0.464322026286307,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,0.97 [0.91-1.05],0.464587618676854,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD83,CD83 antigen,Inverse variance weighted,5,1.06 [0.91-1.22],0.468037479296135,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD164,Sialomucin core protein 24,Inverse variance weighted,3,1.07 [0.89-1.28],0.469504554283985,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,Inverse variance weighted,10,0.97 [0.88-1.06],0.47111442337482,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,24,0.97 [0.91-1.04],0.472096113601768,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,Inverse variance weighted,6,1.07 [0.89-1.28],0.473487396644187,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KLK11,Kallikrein-11,Inverse variance weighted,6,1.03 [0.96-1.1],0.474420056774736,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,17,1.02 [0.96-1.09],0.474750692034565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,5,1.06 [0.91-1.24],0.475136532836574,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NUCB2,Nucleobindin-2,Inverse variance weighted,24,1.03 [0.96-1.1],0.476002227591638,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TIMP2,Metalloproteinase inhibitor 2,Inverse variance weighted,2,1.13 [0.8-1.6],0.476522833293228,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,0.95 [0.84-1.09],0.477157218464245,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,44,0.98 [0.94-1.03],0.478551490774267,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,1.05 [0.91-1.21],0.479034094310254,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,12,1.03 [0.95-1.11],0.481649942092001,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.02 [0.96-1.09],0.482471037578314,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,THBS2,Thrombospondin-2,Inverse variance weighted,16,1.04 [0.94-1.14],0.484082730918895,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,0.97 [0.89-1.05],0.484553789010016,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.95 [0.82-1.1],0.485115165286703,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LAMB1,Laminin subunit beta-1,Inverse variance weighted,35,0.98 [0.93-1.04],0.487311491023749,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TXNDC5,Thioredoxin domain-containing protein 5,Inverse variance weighted,3,1.08 [0.87-1.34],0.487466640198094,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,1.01 [0.97-1.06],0.488435370687938,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CDH1,Cadherin-1,Wald ratio,1,1.25 [0.67-2.34],0.489020016444632,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ASAH1,Acid ceramidase,Inverse variance weighted,20,0.98 [0.94-1.03],0.489651424356867,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SELE,E-selectin,Inverse variance weighted,4,0.91 [0.69-1.19],0.490477714557605,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PHLDB1,Pleckstrin homology-like domain family B member 1,Wald ratio,1,1.27 [0.64-2.5],0.490801367925128,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DKK3,Dickkopf-related protein 3,Inverse variance weighted,13,0.98 [0.92-1.04],0.492484279384773,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NCAN,Neurocan core protein,Inverse variance weighted,3,0.93 [0.75-1.15],0.493167806918312,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,3,1.06 [0.89-1.26],0.494227074692007,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,1.02 [0.97-1.07],0.494875865846021,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,1.07 [0.88-1.29],0.500340692484287,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CNTN5,Contactin-5,Inverse variance weighted,28,0.98 [0.93-1.03],0.500464765800358,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1.01 [0.98-1.04],0.50223852484831,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PGF,Placenta growth factor,Inverse variance weighted,2,0.77 [0.36-1.65],0.502443674142846,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,9,0.95 [0.83-1.09],0.503546929636,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL17,C-C motif chemokine 17,Inverse variance weighted,9,1.04 [0.92-1.19],0.503950679642821,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,Inverse variance weighted,2,0.92 [0.72-1.18],0.508180114542995,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,4,1.04 [0.92-1.18],0.513776362211183,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,25,1.01 [0.97-1.06],0.514425204090892,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",Inverse variance weighted,17,0.98 [0.9-1.05],0.517474573119065,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,10,1.03 [0.95-1.12],0.518185817055651,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,2,0.9 [0.64-1.25],0.519671096067399,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,22,1.02 [0.96-1.08],0.520295204505471,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,8,0.97 [0.87-1.07],0.520301878702245,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.95 [0.81-1.11],0.5212255422858,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,1.03 [0.95-1.11],0.521348032506094,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.91 [0.69-1.21],0.52185313916467,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,1.08 [0.85-1.36],0.522445284445751,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,8,1.04 [0.93-1.16],0.525328241012056,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DPT,Dermatopontin,Inverse variance weighted,21,0.98 [0.9-1.05],0.526131254088894,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MTUS1,Microtubule-associated tumor suppressor 1,Inverse variance weighted,5,0.95 [0.79-1.12],0.526449501726779,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.25 [0.63-2.46],0.526864892642615,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,1.02 [0.96-1.09],0.528015347199386,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL1RL2,Interleukin-1 receptor-like 2,Inverse variance weighted,30,0.98 [0.92-1.04],0.529065986064117,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.93 [0.75-1.16],0.529757805202626,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MPO,Myeloperoxidase,Inverse variance weighted,11,1.02 [0.95-1.1],0.530327702800509,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,1.03 [0.94-1.12],0.532670418698011,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,30,1.01 [0.98-1.04],0.533412135494278,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ALCAM,CD166 antigen,Inverse variance weighted,6,1.06 [0.88-1.27],0.533898468957856,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.1 [0.81-1.5],0.538065353004441,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,27,1.02 [0.96-1.08],0.540362955991377,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GBP1,Guanylate-binding protein 1,Inverse variance weighted,10,0.97 [0.89-1.06],0.540475032223892,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PALM2,Paralemmin-2,Inverse variance weighted,8,1.04 [0.92-1.17],0.540661721281368,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,0.95 [0.8-1.12],0.541021056052975,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TALDO1,Transaldolase,Inverse variance weighted,3,0.93 [0.72-1.19],0.543822104817301,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,0.96 [0.85-1.09],0.545782371986615,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,15,0.98 [0.91-1.05],0.548102015576082,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NRP1,Neuropilin-1,Inverse variance weighted,12,0.97 [0.87-1.07],0.549259659915975,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,1.06 [0.88-1.26],0.549441451065803,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,0.97 [0.89-1.07],0.551225444259621,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DPP10,Inactive dipeptidyl peptidase 10,Inverse variance weighted,13,1.03 [0.93-1.14],0.552508866164443,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADAMTSL4,ADAMTS-like protein 4,Inverse variance weighted,12,1.02 [0.94-1.11],0.554360682843618,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ANXA5,Annexin A5,Inverse variance weighted,2,0.92 [0.7-1.21],0.556739639065263,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,11,1.03 [0.94-1.13],0.557770207699918,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADIPOQ,Adiponectin,Inverse variance weighted,13,0.97 [0.86-1.08],0.55876840110929,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,41,1.01 [0.98-1.05],0.559014506319854,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,40,0.99 [0.95-1.03],0.55936835447557,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,0.94 [0.75-1.17],0.559592508355531,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.03 [0.93-1.15],0.560720190327348,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ELN,Elastin,Inverse variance weighted,2,1.12 [0.76-1.65],0.5623780898969,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.03 [0.93-1.15],0.562959762212457,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,10,1.03 [0.93-1.15],0.563653090928245,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,7,0.95 [0.81-1.12],0.563687048373406,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,21,1.02 [0.95-1.09],0.564047063354891,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,Wald ratio,1,1.27 [0.56-2.88],0.56515944167984,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FBLN2,Fibulin-2,Inverse variance weighted,11,0.98 [0.89-1.06],0.565356622282628,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CRH,Corticoliberin,Inverse variance weighted,11,1.02 [0.95-1.1],0.566439451855361,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CDH3,Cadherin-3,Inverse variance weighted,2,1.1 [0.79-1.55],0.569007994666405,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,0.91 [0.66-1.26],0.570985536728229,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,1.13 [0.73-1.76],0.572962551300039,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCN5,CCN family member 5,Inverse variance weighted,8,1.07 [0.85-1.34],0.574088135704488,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,0.93 [0.73-1.19],0.574270614501337,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,0.99 [0.94-1.04],0.574750944121154,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SPINK6,Serine protease inhibitor Kazal-type 6,Inverse variance weighted,12,0.96 [0.84-1.1],0.5750541879746,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,1.05 [0.88-1.26],0.575114687241289,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,AKR7L,Aflatoxin B1 aldehyde reductase member 4,Inverse variance weighted,6,0.93 [0.72-1.2],0.575607341494052,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.12 [0.75-1.69],0.576493119988335,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SBSN,Suprabasin,Inverse variance weighted,17,1.02 [0.96-1.07],0.577471679984886,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,1.02 [0.96-1.08],0.578714556292512,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,19,0.99 [0.96-1.03],0.581532340758508,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EPO,Erythropoietin,Inverse variance weighted,5,0.85 [0.47-1.53],0.583694001169617,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.81 [0.38-1.73],0.584171549759106,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FABP6,Gastrotropin,Wald ratio,1,0.94 [0.75-1.17],0.584510097685699,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FAM3D,Protein FAM3D,Inverse variance weighted,17,0.97 [0.85-1.09],0.585047642885043,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,0.98 [0.93-1.04],0.587888885510495,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,F3,Tissue factor,Inverse variance weighted,11,1.03 [0.92-1.15],0.588083637363615,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,9,0.98 [0.9-1.06],0.591067054866412,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,3,1.05 [0.88-1.26],0.592032175034661,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,3,1.15 [0.69-1.91],0.595319213365701,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,C7,Complement component C7,Inverse variance weighted,38,1.01 [0.97-1.05],0.597234442351789,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,0.95 [0.8-1.13],0.597514399864414,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DPP7,Dipeptidyl peptidase 2,Inverse variance weighted,19,0.99 [0.95-1.03],0.599090629602134,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,2,0.92 [0.68-1.25],0.599383230000718,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MEP1B,Meprin A subunit beta,Inverse variance weighted,46,0.99 [0.96-1.02],0.600722985817041,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,30,0.98 [0.92-1.05],0.602752215605337,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CRYBB2,Beta-crystallin B2,Wald ratio,1,0.89 [0.58-1.37],0.602894741735688,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,0.98 [0.92-1.05],0.60338862728166,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,7,1.02 [0.94-1.12],0.604115227868875,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CST1,Cystatin-SN,Inverse variance weighted,25,1.01 [0.96-1.07],0.60469110418297,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GOT1,"Aspartate aminotransferase, cytoplasmic",Wald ratio,1,1.21 [0.59-2.5],0.604776729619864,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CALB1,Calbindin,Inverse variance weighted,2,1.11 [0.75-1.64],0.605852009591131,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LCN15,Lipocalin-15,Inverse variance weighted,20,0.99 [0.94-1.03],0.607274849790454,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PTN,Pleiotrophin,Inverse variance weighted,4,1.09 [0.78-1.52],0.607517706884509,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,0.99 [0.95-1.03],0.60798927032568,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL32,Interleukin-32,Inverse variance weighted,11,0.97 [0.87-1.09],0.608830873625425,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD276,CD276 antigen,Inverse variance weighted,20,1.01 [0.96-1.07],0.60898004057591,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TFRC,Transferrin receptor protein 1,Inverse variance weighted,28,0.98 [0.92-1.05],0.612315700188422,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BCAM,Basal cell adhesion molecule,Inverse variance weighted,12,1.03 [0.93-1.13],0.613647953706365,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,0.96 [0.81-1.13],0.613988742752132,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CTSZ,Cathepsin Z,Inverse variance weighted,3,1.03 [0.93-1.13],0.614684678732844,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,4,0.98 [0.88-1.08],0.615173417277809,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MMP10,Stromelysin-2,Inverse variance weighted,22,0.98 [0.92-1.05],0.61639031856405,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CLC,Galectin-10,Wald ratio,1,1.09 [0.77-1.55],0.617183187338867,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HGF,Hepatocyte growth factor,Inverse variance weighted,2,1.09 [0.77-1.56],0.617658411170649,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PSAP,Prosaposin,Inverse variance weighted,5,0.96 [0.84-1.11],0.619488971218663,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,6,1.03 [0.91-1.16],0.620816108226586,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HJV,Hemojuvelin,Wald ratio,1,0.96 [0.82-1.13],0.622361953826122,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,0.99 [0.93-1.04],0.623011956760694,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SDC1,Syndecan-1,Inverse variance weighted,2,0.94 [0.73-1.21],0.623275268471431,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,0.98 [0.91-1.06],0.623293975440703,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,6,1.07 [0.83-1.37],0.623940222170017,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LGALS9,Galectin-9,Inverse variance weighted,26,1.02 [0.95-1.08],0.624678864563516,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,Inverse variance weighted,44,1.01 [0.98-1.04],0.626084811499457,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,33,0.99 [0.94-1.03],0.626344837121278,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BSG,Basigin,Wald ratio,1,0.95 [0.77-1.17],0.628612542940206,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,8,0.95 [0.77-1.17],0.630510371560921,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,3,1.08 [0.78-1.49],0.632039627724448,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MSLN,Mesothelin,Inverse variance weighted,25,0.99 [0.94-1.04],0.633248329425168,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PRELP,Prolargin,Inverse variance weighted,9,1.02 [0.93-1.13],0.633548005879824,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FGR,Tyrosine-protein kinase Fgr,Inverse variance weighted,2,0.93 [0.69-1.25],0.634003720261978,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.05 [0.86-1.28],0.635117878550032,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SPRR3,Small proline-rich protein 3,Inverse variance weighted,11,0.98 [0.89-1.08],0.635161268029646,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,0.97 [0.86-1.09],0.636423516970241,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.11 [0.72-1.71],0.637738648453632,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CHGA,Chromogranin-A,Inverse variance weighted,3,1.08 [0.77-1.52],0.637893721099385,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ELOA,Elongin-A,Inverse variance weighted,2,1.07 [0.8-1.45],0.637957029274658,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.13 [0.68-1.86],0.639072991003949,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,1.04 [0.87-1.25],0.639305049225121,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FUOM,Fucose mutarotase,Inverse variance weighted,3,1.06 [0.82-1.38],0.641627557204109,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,APOA4,Apolipoprotein A-IV,Wald ratio,1,0.84 [0.4-1.76],0.641813625692898,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,7,0.99 [0.93-1.04],0.642240425603707,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,6,0.97 [0.85-1.11],0.643686941981039,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,7,0.98 [0.89-1.07],0.644454027657231,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,Wald ratio,1,1.06 [0.83-1.35],0.64464565270513,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,0.96 [0.79-1.16],0.645932380648197,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,2,1.05 [0.86-1.27],0.647202188068812,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,1.03 [0.91-1.15],0.647693501312462,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BCAN,Brevican core protein,Inverse variance weighted,3,1.03 [0.91-1.17],0.647984689015964,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SNCG,Gamma-synuclein,Inverse variance weighted,36,1.01 [0.97-1.06],0.648323907355113,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.93 [0.7-1.25],0.648550664012851,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,POSTN,Periostin,Inverse variance weighted,10,1.02 [0.94-1.11],0.651427895284367,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SCN4B,Sodium channel subunit beta-4,Inverse variance weighted,24,0.99 [0.94-1.04],0.652636678705426,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.97 [0.86-1.1],0.652667770422874,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,0.98 [0.91-1.06],0.654326869490969,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,21,1.01 [0.95-1.08],0.656119591199443,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,6,1.03 [0.91-1.17],0.65727802003284,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.94 [0.73-1.22],0.659036954378986,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,0.97 [0.85-1.11],0.65939597060742,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.93 [0.67-1.29],0.661986048298137,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Inverse variance weighted,27,1.02 [0.94-1.1],0.663712750765496,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCN3,CCN family member 3,Inverse variance weighted,19,1.02 [0.93-1.13],0.664765272704266,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,0.96 [0.79-1.17],0.66541080312714,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,4,0.98 [0.88-1.08],0.666728876312252,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ITGA11,Integrin alpha-11,Inverse variance weighted,8,1.02 [0.93-1.13],0.666749883602483,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VWF,von Willebrand factor,Inverse variance weighted,2,1.11 [0.69-1.79],0.669923416759496,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,34,1.01 [0.97-1.05],0.673134946895385,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FOLR1,Folate receptor alpha,Inverse variance weighted,5,0.95 [0.74-1.21],0.673406143566968,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,1.16 [0.58-2.34],0.673983042918714,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,Inverse variance weighted,10,0.97 [0.85-1.11],0.677162932965099,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CLGN,Calmegin,Inverse variance weighted,23,0.99 [0.93-1.05],0.678512514094869,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.97 [0.83-1.13],0.680100933452148,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,1.02 [0.93-1.12],0.686030610420701,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GFAP,Glial fibrillary acidic protein,Inverse variance weighted,4,0.95 [0.73-1.23],0.686438559037776,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TCOF1,Treacle protein,Wald ratio,1,0.89 [0.5-1.59],0.686503444889281,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SCG2,Secretogranin-2,Wald ratio,1,0.88 [0.47-1.63],0.686985810460528,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1.05 [0.82-1.34],0.687071200347257,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,0.94 [0.71-1.25],0.687630743257528,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,Inverse variance weighted,43,0.99 [0.97-1.02],0.688071783514614,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.05 [0.83-1.33],0.688598638996258,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,11,1.02 [0.93-1.11],0.689489155066286,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,30,0.99 [0.92-1.05],0.692708121804325,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,1.02 [0.91-1.15],0.693270842769302,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,18,0.99 [0.94-1.05],0.69398209513925,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,1.02 [0.91-1.15],0.694361277587578,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,0.97 [0.81-1.15],0.694528150967857,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,0.97 [0.83-1.13],0.69725833065657,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,WFDC1,WAP four-disulfide core domain protein 1,Inverse variance weighted,6,0.98 [0.9-1.07],0.697958611248931,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SIAE,Sialate O-acetylesterase,Inverse variance weighted,3,1.03 [0.9-1.17],0.700295725582952,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RBP2,Retinol-binding protein 2,Wald ratio,1,1.1 [0.68-1.78],0.701310797558003,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,0.98 [0.88-1.09],0.701450221841392,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RSPO1,R-spondin-1,Inverse variance weighted,5,1.02 [0.91-1.15],0.702398124228535,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,28,1.01 [0.96-1.06],0.704875470193432,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,1.02 [0.93-1.11],0.705311808985297,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,AHNAK2,Protein AHNAK2,Inverse variance weighted,4,1.02 [0.9-1.16],0.70732392101167,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,1.03 [0.87-1.22],0.707411790121329,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,0.99 [0.93-1.05],0.70811948647273,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,Wald ratio,1,1.12 [0.63-1.99],0.70842037200982,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",Inverse variance weighted,2,1.04 [0.86-1.24],0.708479171960209,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ENAH,Protein enabled homolog,Inverse variance weighted,2,0.95 [0.74-1.23],0.709724110110882,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MDK,Midkine,Inverse variance weighted,4,1.04 [0.86-1.26],0.710084757974991,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SERPINA11,Serpin A11,Inverse variance weighted,31,1.01 [0.96-1.06],0.711046087943587,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,3,1.04 [0.83-1.32],0.711690315738728,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SCGB3A2,Secretoglobin family 3A member 2,Inverse variance weighted,5,1.02 [0.91-1.14],0.712148085143315,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,0.91 [0.57-1.47],0.712150391955736,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL15,Interleukin-15,Wald ratio,1,1.67 [0.11-26.19],0.714008179146512,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,11,1.02 [0.9-1.16],0.714353359449173,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FCN1,Ficolin-1,Inverse variance weighted,28,1.01 [0.95-1.08],0.714672510176254,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,1.13 [0.58-2.23],0.714891863059594,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,1.04 [0.83-1.31],0.715775178818045,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MARCO,Macrophage receptor MARCO,Inverse variance weighted,10,1.02 [0.93-1.12],0.718818819439104,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,1.02 [0.91-1.15],0.719218561745964,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,1.01 [0.96-1.05],0.719429916925016,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,0.99 [0.95-1.04],0.719483155706115,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.97 [0.85-1.12],0.719668285492887,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CST3,Cystatin-C,Inverse variance weighted,10,0.98 [0.87-1.1],0.719823469889263,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,30,0.99 [0.95-1.04],0.720319432440441,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,0.99 [0.94-1.05],0.725806245570094,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,Inverse variance weighted,19,1.02 [0.92-1.13],0.726799099819401,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CFD,Complement factor D,Inverse variance weighted,11,1.02 [0.9-1.16],0.72989493415682,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DSC2,Desmocollin-2,Inverse variance weighted,9,1.02 [0.9-1.15],0.73275093598229,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,18,0.99 [0.91-1.07],0.735582496689014,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,4,1.03 [0.86-1.24],0.73581759577962,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CWC15,Spliceosome-associated protein CWC15 homolog,Wald ratio,1,1.1 [0.65-1.86],0.735942948375854,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LAYN,Layilin,Inverse variance weighted,20,0.99 [0.9-1.07],0.738236516267649,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,8,0.98 [0.89-1.09],0.740385986280097,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,OSM,Oncostatin-M,Wald ratio,1,0.93 [0.61-1.42],0.748867031881794,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,1.01 [0.93-1.11],0.749463642267444,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADGRE1,Adhesion G protein-coupled receptor E1,Inverse variance weighted,14,1.01 [0.95-1.08],0.750161484966888,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BMP10,Bone morphogenetic protein 10,Inverse variance weighted,10,1.02 [0.92-1.11],0.75030195402611,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,1.01 [0.97-1.05],0.752605185892869,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.95 [0.69-1.31],0.753660548042894,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CX3CL1,Fractalkine,Inverse variance weighted,9,0.98 [0.86-1.12],0.75642419392393,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,1.11 [0.56-2.22],0.75723187312101,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,UNC5D,Netrin receptor UNC5D,Wald ratio,1,0.69 [0.07-7.26],0.759020136534929,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,0.98 [0.84-1.14],0.759997921413068,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,19,1.01 [0.96-1.06],0.761063862872594,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,9,1.02 [0.91-1.14],0.76360975801786,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FDX1,"Adrenodoxin, mitochondrial",Wald ratio,1,0.92 [0.53-1.6],0.764163085276774,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GPR158,Probable G-protein coupled receptor 158,Wald ratio,1,1.07 [0.68-1.7],0.765700427425044,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PGA4,Pepsin A-4,Inverse variance weighted,2,0.93 [0.57-1.52],0.767474950102238,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DBI,Acyl-CoA-binding protein,Inverse variance weighted,9,0.99 [0.9-1.09],0.769911512495909,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,1.04 [0.78-1.39],0.770512722261311,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,6,0.97 [0.8-1.18],0.770695686480953,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,1.02 [0.9-1.15],0.776522398857329,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,32,1.01 [0.96-1.05],0.777947383018051,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1.01 [0.92-1.11],0.778287357791959,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DSG2,Desmoglein-2,Inverse variance weighted,11,0.98 [0.88-1.1],0.778508666984775,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,3,1.05 [0.73-1.53],0.781280396870657,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,Inverse variance weighted,14,0.98 [0.87-1.11],0.783513060595427,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,1.01 [0.92-1.12],0.784609481991112,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,50,1 [0.97-1.04],0.784991206093852,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.98 [0.87-1.11],0.785230589015205,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,10,1.01 [0.92-1.11],0.785543476617966,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,13,0.99 [0.91-1.07],0.785961974143115,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,F2R,Proteinase-activated receptor 1,Inverse variance weighted,2,0.95 [0.64-1.41],0.787020326792059,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FCRL2,Fc receptor-like protein 2,Inverse variance weighted,36,0.99 [0.94-1.04],0.788410902830454,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MMP7,Matrilysin,Inverse variance weighted,13,1.01 [0.93-1.1],0.78864056332455,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,STAB2,Stabilin-2,Inverse variance weighted,20,0.99 [0.94-1.05],0.791575628141312,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,0.97 [0.76-1.24],0.791596139237054,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PTS,6-pyruvoyl tetrahydrobiopterin synthase,Inverse variance weighted,3,1.02 [0.89-1.16],0.792902209537318,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD70,CD70 antigen,Inverse variance weighted,28,0.99 [0.95-1.04],0.794252970882873,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,1.02 [0.86-1.22],0.79584719705361,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,0.99 [0.92-1.07],0.796274889030604,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,0.98 [0.85-1.13],0.798633190836194,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CTSE,Cathepsin E,Inverse variance weighted,14,1.01 [0.93-1.1],0.803336096583045,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,27,0.99 [0.96-1.04],0.804285869562194,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CLEC4G,C-type lectin domain family 4 member G,Inverse variance weighted,6,0.98 [0.87-1.11],0.804450993947881,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PRTG,Protogenin,Inverse variance weighted,19,1.01 [0.96-1.06],0.808559277816453,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PAXX,Protein PAXX,Inverse variance weighted,3,1.02 [0.86-1.22],0.808624395606049,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,0.98 [0.83-1.16],0.808896408604028,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,1.09 [0.54-2.2],0.810607880851186,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SSNA1,Sjoegren syndrome nuclear autoantigen 1,Wald ratio,1,1.08 [0.57-2.04],0.811029599741643,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,15,0.99 [0.92-1.07],0.81148910671338,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KLK8,Kallikrein-8,Inverse variance weighted,12,1.01 [0.92-1.12],0.814074968267766,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FAM171B,Protein FAM171B,Inverse variance weighted,21,0.99 [0.92-1.07],0.814412465670606,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,1.04 [0.75-1.44],0.821523782417391,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Wald ratio,1,0.97 [0.75-1.26],0.822083790087491,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,0.97 [0.76-1.24],0.822083790087492,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,1.01 [0.96-1.06],0.822219063333642,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MME,Neprilysin,Inverse variance weighted,3,0.96 [0.67-1.37],0.822434066831328,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.02 [0.84-1.25],0.823662613748235,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,0.99 [0.9-1.09],0.82416258442848,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.01 [0.95-1.06],0.824864260696709,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,OLFM4,Olfactomedin-4,Inverse variance weighted,37,1 [0.97-1.04],0.826698027295083,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL18,Interleukin-18,Inverse variance weighted,16,0.98 [0.82-1.17],0.826803801843764,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MMP3,Stromelysin-1,Inverse variance weighted,34,1.01 [0.94-1.08],0.827413884860186,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.97 [0.76-1.25],0.827877544747061,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,21,0.99 [0.94-1.05],0.828866985047477,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1.01 [0.93-1.09],0.829044913049424,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,0.98 [0.82-1.18],0.83107588525364,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,2,1.02 [0.84-1.24],0.832135010390131,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,16,0.99 [0.93-1.06],0.833041133089665,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PKD2,Polycystin-2,Inverse variance weighted,3,0.92 [0.43-1.98],0.833679943166607,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Wald ratio,1,0.97 [0.75-1.27],0.83524372482826,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,3,1.01 [0.93-1.09],0.835426451592974,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MFGE8,Lactadherin,Inverse variance weighted,11,1.01 [0.93-1.1],0.83634047762035,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,2,0.97 [0.7-1.33],0.83739435176726,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,1.01 [0.92-1.1],0.838183410994265,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,22,1 [0.95-1.04],0.840062891309155,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CXCL8,Interleukin-8,Inverse variance weighted,6,0.98 [0.78-1.23],0.84137529652904,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EDN1,Endothelin-1,Inverse variance weighted,3,1.02 [0.86-1.21],0.842078101506288,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,0.98 [0.78-1.23],0.842296316016589,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KLK6,Kallikrein-6,Inverse variance weighted,4,1.01 [0.88-1.17],0.842760973475303,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,0.99 [0.85-1.14],0.842822609560974,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,5,0.99 [0.86-1.13],0.844915903494532,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,4,1.01 [0.9-1.14],0.845066786422553,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,1.05 [0.62-1.8],0.8462906322737,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SDC4,Syndecan-4,Inverse variance weighted,8,1.02 [0.83-1.25],0.850995540560426,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,1.01 [0.92-1.1],0.851017301544723,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GPR15L,Protein GPR15L,Inverse variance weighted,9,0.99 [0.9-1.09],0.85127203674974,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,5,0.99 [0.94-1.05],0.854638033567801,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,1.01 [0.89-1.15],0.856165317268266,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SEZ6,Seizure protein 6 homolog,Inverse variance weighted,2,0.97 [0.66-1.41],0.857980760562973,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.02 [0.79-1.33],0.858773281601423,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,1 [0.95-1.05],0.860005129338364,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,7,1.01 [0.89-1.15],0.860081624891081,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,Inverse variance weighted,11,1.01 [0.9-1.13],0.862858697640754,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1 [0.95-1.05],0.864495944006747,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,1.01 [0.88-1.17],0.864720527639725,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NECTIN4,Nectin-4,Inverse variance weighted,7,1.01 [0.9-1.14],0.865721548402938,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CYTL1,Cytokine-like protein 1,Inverse variance weighted,7,1 [0.96-1.04],0.867677108133406,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,Inverse variance weighted,17,1 [0.95-1.05],0.8682522006712,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CA4,Carbonic anhydrase 4,Inverse variance weighted,12,0.99 [0.93-1.06],0.868672048618684,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,2,1.04 [0.64-1.68],0.870949472915674,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNC,Tenascin,Inverse variance weighted,12,0.99 [0.89-1.1],0.871893958163149,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,6,0.99 [0.85-1.14],0.872367563046633,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,28,1 [0.95-1.04],0.87717127646404,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TMSB10,Thymosin beta-10,Wald ratio,1,0.96 [0.58-1.59],0.877812312960088,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,8,1.01 [0.89-1.14],0.878353770808328,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,4,0.98 [0.8-1.21],0.879863972016743,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,7,0.99 [0.9-1.09],0.881220988794664,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADM,Pro-adrenomedullin,Inverse variance weighted,2,1.02 [0.77-1.35],0.882756671929696,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ECHS1,"Enoyl-CoA hydratase, mitochondrial",Inverse variance weighted,4,1.01 [0.86-1.2],0.883015706071898,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PRSS8,Prostasin,Inverse variance weighted,5,0.98 [0.79-1.22],0.886495310859687,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,21,0.99 [0.93-1.07],0.887957857635712,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,Inverse variance weighted,6,1.02 [0.78-1.32],0.888141697960548,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1.01 [0.91-1.12],0.888173330868796,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SCG3,Secretogranin-3,Inverse variance weighted,32,1 [0.95-1.06],0.890926665297187,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,1 [0.95-1.07],0.891170045223395,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.99 [0.91-1.09],0.89496359134979,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,0.96 [0.54-1.71],0.896245919530588,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SPON1,Spondin-1,Inverse variance weighted,21,1 [0.93-1.08],0.897250858982394,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VIT,Vitrin,Inverse variance weighted,25,1 [0.96-1.05],0.89762244576857,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,0.99 [0.89-1.11],0.897664164012196,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,10,0.99 [0.9-1.1],0.899345485691297,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD27,CD27 antigen,Inverse variance weighted,9,0.99 [0.9-1.1],0.899446519217299,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PXN,Paxillin,Inverse variance weighted,26,1 [0.95-1.06],0.901014076954865,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,25,1 [0.97-1.03],0.902380878055242,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,0.99 [0.87-1.14],0.90492512041253,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,COLEC12,Collectin-12,Inverse variance weighted,11,1.01 [0.88-1.15],0.906123494762198,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KLK4,Kallikrein-4,Inverse variance weighted,17,1 [0.94-1.06],0.90708988118016,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,1.01 [0.82-1.26],0.907288613892731,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ACE,Angiotensin-converting enzyme,Inverse variance weighted,26,1 [0.94-1.06],0.907665450582903,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,1 [0.93-1.07],0.909120610332098,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,1 [0.92-1.08],0.91065770446009,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CYB5R2,NADH-cytochrome b5 reductase 2,Inverse variance weighted,14,1 [0.93-1.06],0.911183992967818,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CST6,Cystatin-M,Inverse variance weighted,2,0.99 [0.86-1.15],0.911906213222988,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,9,1.01 [0.83-1.24],0.911918113953499,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CALCA,Calcitonin,Inverse variance weighted,5,1.02 [0.76-1.37],0.912801538375269,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PDCD5,Programmed cell death protein 5,Inverse variance weighted,14,1 [0.93-1.09],0.913568846141984,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,15,1 [0.92-1.07],0.915524343089317,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SCPEP1,Retinoid-inducible serine carboxypeptidase,Inverse variance weighted,9,0.99 [0.78-1.25],0.919952234151775,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DMP1,Dentin matrix acidic phosphoprotein 1,Wald ratio,1,1.03 [0.58-1.84],0.920775028782593,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NEO1,Neogenin,Wald ratio,1,1.02 [0.69-1.5],0.921032471664136,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ITGA5,Integrin alpha-5,Wald ratio,1,1.02 [0.63-1.68],0.922276627818089,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,0.98 [0.72-1.35],0.923394718436679,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MMP1,Interstitial collagenase,Inverse variance weighted,31,1 [0.95-1.05],0.923460933667525,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SERPINA5,Plasma serine protease inhibitor,Inverse variance weighted,12,1 [0.92-1.1],0.924070518457042,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,1 [0.96-1.05],0.924631498251439,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,11,0.99 [0.88-1.13],0.92905002834583,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,16,1 [0.95-1.06],0.931149339353398,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NPPC,C-type natriuretic peptide,Wald ratio,1,1.03 [0.51-2.08],0.932795078901707,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,1 [0.91-1.11],0.933108174552204,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MVK,Mevalonate kinase,Inverse variance weighted,2,1.01 [0.74-1.39],0.935527549314547,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,1 [0.93-1.09],0.936855504292329,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CDH6,Cadherin-6,Inverse variance weighted,29,1 [0.95-1.05],0.938479079452936,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,0.99 [0.68-1.43],0.939324121929323,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,41,1 [0.97-1.03],0.940246111171094,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ALPP,"Alkaline phosphatase, placental type",Inverse variance weighted,31,1 [0.95-1.05],0.940800438047129,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,15,1 [0.91-1.1],0.947953713444609,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,1 [0.94-1.07],0.948478883099927,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,OCLN,Occludin,Inverse variance weighted,2,0.99 [0.65-1.49],0.954134367806167,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,1.01 [0.72-1.42],0.954319567923013,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,2,0.99 [0.72-1.37],0.955208137143353,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HMOX2,Heme oxygenase 2,Inverse variance weighted,2,0.99 [0.62-1.58],0.955301852055188,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1 [0.89-1.12],0.95686102425561,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CALB2,Calretinin,Wald ratio,1,1.01 [0.63-1.63],0.960488418657005,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.99 [0.71-1.39],0.96089932076074,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,1 [0.96-1.05],0.962279868659836,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Wald ratio,1,1 [0.9-1.1],0.964829053339604,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,STC1,Stanniocalcin-1,Inverse variance weighted,2,0.99 [0.64-1.53],0.965999165643716,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,1 [0.83-1.2],0.966287024692756,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,OMG,Oligodendrocyte-myelin glycoprotein,Wald ratio,1,1.01 [0.69-1.47],0.967053879520286,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,1 [0.91-1.1],0.971471242688609,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,1 [0.92-1.09],0.972964712700625,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,1 [0.91-1.11],0.973958076581878,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,2,1 [0.74-1.34],0.975460996147527,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,1 [0.93-1.07],0.979917016385747,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NECTIN2,Nectin-2,Inverse variance weighted,5,1 [0.91-1.1],0.981360943484224,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NPTX1,Neuronal pentraxin-1,Inverse variance weighted,17,1 [0.95-1.05],0.982474306956522,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MSTN,Growth/differentiation factor 8,Inverse variance weighted,2,1 [0.83-1.19],0.982736312280253,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADA,Adenosine deaminase,Inverse variance weighted,22,1 [0.95-1.05],0.985361425868558,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,19,1 [0.94-1.07],0.988434528002227,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CBLN4,Cerebellin-4,Inverse variance weighted,11,1 [0.89-1.13],0.989551359995556,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,1 [0.95-1.05],0.990115592088507,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",Wald ratio,1,1 [0.68-1.46],0.990199181927225,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,12,1 [0.91-1.09],0.99036116729389,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,1 [0.95-1.05],0.990514969183927,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,1 [0.54-1.88],0.991052325380401,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PTPRR,Receptor-type tyrosine-protein phosphatase R,Inverse variance weighted,4,1 [0.74-1.36],0.993204022014234,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MUC13,Mucin-13,Inverse variance weighted,9,1 [0.89-1.13],0.993205411932858,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,1 [0.58-1.72],0.99331569186675,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CTSL,Cathepsin L1,Wald ratio,1,1 [0.53-1.89],0.993471945536422,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,1 [0.95-1.05],0.995723541678322,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,1 [0.79-1.27],0.99709479756117,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RETN,Resistin,Inverse variance weighted,9,1 [0.94-1.07],0.997627613596595,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CGA,Glycoprotein hormones alpha chain,Wald ratio,1,1 [0.43-2.34],0.997881538706724,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,18,1.22 [1.09-1.36],0.00031149889636754,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SEMA3G,Semaphorin-3G,Inverse variance weighted,66,1.09 [1.04-1.15],0.000935894580192709,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,3,0.59 [0.43-0.81],0.00100995375456753,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MMP7,Matrilysin,Wald ratio,1,0.65 [0.5-0.85],0.00161781250292802,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,0.64 [0.48-0.85],0.00200680460921562,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,6,0.63 [0.47-0.86],0.00308905175263661,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADIPOQ,Adiponectin,Inverse variance weighted,25,0.87 [0.8-0.96],0.00317487060773375,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SELE,E-selectin,Inverse variance weighted,20,0.92 [0.87-0.97],0.00335312215246698,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GRN,Progranulin,Inverse variance weighted,46,1.08 [1.02-1.14],0.00423155268502094,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DCN,Decorin,Inverse variance weighted,2,2.02 [1.21-3.37],0.00689104342668232,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CST3,Cystatin-C,Inverse variance weighted,3,1.75 [1.14-2.68],0.0097708682809082,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,0.86 [0.77-0.97],0.0102792765643048,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,79,0.95 [0.92-0.99],0.0123355371791293,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,1.23 [1.05-1.44],0.0123789738976516,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,1.16 [1.03-1.31],0.0128339208248889,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,1.24 [1.05-1.47],0.0131864755733019,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADAMTSL4,ADAMTS-like protein 4,Inverse variance weighted,6,1.43 [1.07-1.91],0.0150775358303172,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,0.85 [0.74-0.97],0.0194612244714324,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCN5,CCN family member 5,Inverse variance weighted,12,1.12 [1.02-1.24],0.0206290560223223,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.49 [1.06-2.08],0.0209075565239081,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PENK,Proenkephalin-A,Inverse variance weighted,15,1.14 [1.02-1.28],0.0222746524970272,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PRND,Prion-like protein doppel,Inverse variance weighted,15,1.24 [1.03-1.49],0.0234680643805521,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PVR,Poliovirus receptor,Inverse variance weighted,3,0.62 [0.41-0.94],0.0237755496893861,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CST7,Cystatin-F,Inverse variance weighted,46,0.93 [0.88-0.99],0.0254735748638425,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,19,0.93 [0.88-0.99],0.0257476638296561,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,12,1.26 [1.03-1.54],0.0261001579132633,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RNASE6,Ribonuclease K6,Inverse variance weighted,4,1.54 [1.05-2.24],0.026599562585802,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,0.66 [0.45-0.95],0.0268423009944426,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,0.73 [0.56-0.97],0.0270198697298242,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,0.94 [0.88-0.99],0.0271580381732103,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BCAM,Basal cell adhesion molecule,Inverse variance weighted,22,0.94 [0.88-0.99],0.0277801912313993,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,0.92 [0.86-0.99],0.0281606541153845,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL27,C-C motif chemokine 27,Inverse variance weighted,9,1.32 [1.03-1.71],0.0314923720117976,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KLK8,Kallikrein-8,Inverse variance weighted,5,0.75 [0.58-0.98],0.0334805476649267,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CYTL1,Cytokine-like protein 1,Inverse variance weighted,3,1.49 [1.03-2.16],0.0336290635685783,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,0.81 [0.67-0.98],0.033808940014734,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,4,1.47 [1.03-2.1],0.0341446943902822,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,2.01 [1.04-3.88],0.0374224614448637,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.46 [0.22-0.96],0.0374296484648375,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RNASET2,Ribonuclease T2,Inverse variance weighted,10,0.86 [0.75-0.99],0.0376982479791275,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PXN,Paxillin,Inverse variance weighted,7,0.8 [0.64-0.99],0.0382389415767276,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,AOC3,Membrane primary amine oxidase,Inverse variance weighted,33,0.94 [0.89-1],0.0389425439466279,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Wald ratio,1,2.11 [1.04-4.31],0.0394747442804366,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,0.74 [0.55-0.99],0.0407190529581629,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NRP2,Neuropilin-2,Inverse variance weighted,14,1.19 [1.01-1.42],0.0434341308651835,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,Inverse variance weighted,38,0.92 [0.85-1],0.0434911906843101,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PRSS8,Prostasin,Inverse variance weighted,14,0.86 [0.74-1],0.0442747274544487,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,17,0.95 [0.9-1],0.0461529027917727,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.54 [1.01-2.35],0.0463155662114881,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,OLFM4,Olfactomedin-4,Inverse variance weighted,29,0.91 [0.82-1],0.0493736859302902,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CLEC4G,C-type lectin domain family 4 member G,Inverse variance weighted,14,1.22 [1-1.49],0.0509172601352167,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PTX3,Pentraxin-related protein PTX3,Inverse variance weighted,13,1.07 [1-1.15],0.0521874276972678,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Wald ratio,1,1.56 [0.99-2.45],0.0546032729797758,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,STX8,Syntaxin-8,Wald ratio,1,0.73 [0.52-1.01],0.0549728662589587,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,C7,Complement component C7,Inverse variance weighted,26,1.07 [1-1.15],0.0559698565964783,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD99,CD99 antigen,Inverse variance weighted,4,0.79 [0.62-1.01],0.0561786747251205,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HEPH,Hephaestin,Inverse variance weighted,6,0.86 [0.74-1],0.0562387386378235,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,11,0.88 [0.76-1],0.0579905822709209,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.86 [0.73-1.01],0.0595970452367398,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FGFBP2,Fibroblast growth factor-binding protein 2,Inverse variance weighted,38,0.96 [0.92-1],0.0643872165086891,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,25,1.12 [0.99-1.27],0.0663952829332366,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SLAMF6,SLAM family member 6,Inverse variance weighted,2,0.64 [0.4-1.03],0.066876485860811,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,20,0.92 [0.84-1.01],0.0679807439615699,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MMP8,Neutrophil collagenase,Inverse variance weighted,10,1.14 [0.99-1.32],0.0694199786243443,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GHR,Growth hormone receptor,Inverse variance weighted,26,0.9 [0.8-1.01],0.0696033298313485,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.2 [0.99-1.47],0.0698600658795061,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,1.11 [0.99-1.25],0.0717776760800191,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MDK,Midkine,Inverse variance weighted,14,1.15 [0.99-1.35],0.0727331242657571,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CTSC,Dipeptidyl peptidase 1,Inverse variance weighted,12,0.86 [0.73-1.01],0.0748421456759487,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,0.73 [0.52-1.03],0.0751755760897011,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GRP,Gastrin-releasing peptide,Inverse variance weighted,21,1.05 [0.99-1.11],0.0758744298109628,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TCOF1,Treacle protein,Wald ratio,1,1.86 [0.94-3.68],0.0763698134100247,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PSIP1,PC4 and SFRS1-interacting protein,Wald ratio,1,0.52 [0.26-1.07],0.0764548975423516,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,1.13 [0.99-1.29],0.0778121940241673,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,15,1.13 [0.98-1.31],0.0829112402416252,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EFNA1,Ephrin-A1,Inverse variance weighted,3,1.3 [0.96-1.75],0.0886251889826432,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,1.31 [0.96-1.8],0.089724426104696,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CFP,Properdin,Inverse variance weighted,17,0.89 [0.78-1.02],0.0897355752568768,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SCG2,Secretogranin-2,Inverse variance weighted,2,1.38 [0.95-2],0.0909205909566178,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PKD2,Polycystin-2,Inverse variance weighted,3,0.61 [0.34-1.09],0.0924480426639624,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,6,0.81 [0.63-1.04],0.0980980924581489,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PSAPL1,Proactivator polypeptide-like 1,Inverse variance weighted,50,0.93 [0.85-1.01],0.0991802719844904,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MENT,Protein MENT,Inverse variance weighted,28,1.06 [0.99-1.13],0.0994253180582251,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EGLN1,Egl nine homolog 1,Wald ratio,1,1.78 [0.89-3.53],0.100919610995354,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,13,1.14 [0.97-1.35],0.101358966972347,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.5 [0.92-2.42],0.101690689192654,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SNRPB2,U2 small nuclear ribonucleoprotein B'',Inverse variance weighted,2,0.64 [0.37-1.09],0.101985266574045,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,AMBP,Protein AMBP,Inverse variance weighted,5,1.16 [0.97-1.38],0.103084196633316,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,0.57 [0.29-1.12],0.103338811311187,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,0.92 [0.83-1.02],0.104041777241485,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,38,0.94 [0.88-1.01],0.104440433743624,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,1.18 [0.97-1.44],0.104441638907933,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Inverse variance weighted,35,0.95 [0.9-1.01],0.108764667687851,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,1.14 [0.97-1.33],0.108897151532633,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.11 [0.98-1.25],0.110092914391388,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,1.12 [0.97-1.3],0.110504545938622,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SERPINB8,Serpin B8,Inverse variance weighted,29,0.97 [0.94-1.01],0.113323864974032,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,Inverse variance weighted,59,0.97 [0.93-1.01],0.115058095969867,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,9,0.87 [0.72-1.04],0.116420384439244,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,8,1.2 [0.95-1.51],0.117237802629161,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,0.96 [0.91-1.01],0.117807092021455,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.57 [0.89-2.77],0.118325474915348,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,4,0.74 [0.51-1.08],0.118837521479364,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.9 [0.8-1.03],0.119025762435922,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.75 [0.52-1.08],0.119736269957703,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PRTG,Protogenin,Inverse variance weighted,8,0.82 [0.64-1.05],0.120310671640098,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,1.17 [0.96-1.44],0.121640831729905,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,APOC1,Apolipoprotein C-I,Inverse variance weighted,12,0.9 [0.78-1.03],0.126785117942684,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,OMD,Osteomodulin,Inverse variance weighted,15,1.09 [0.98-1.22],0.127606631348095,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.1 [0.97-1.25],0.127648270135704,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,F9,Coagulation factor IX,Inverse variance weighted,3,0.76 [0.53-1.09],0.1296377984457,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FOLR2,Folate receptor beta,Inverse variance weighted,14,0.9 [0.78-1.03],0.131869976584088,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,THBD,Thrombomodulin,Inverse variance weighted,11,0.91 [0.81-1.03],0.13401880093875,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.24 [0.93-1.65],0.13601472851737,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,18,0.93 [0.84-1.02],0.136607330026484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,Inverse variance weighted,2,1.77 [0.83-3.76],0.136987876078601,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.79 [0.58-1.08],0.137025488696333,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1.07 [0.98-1.17],0.137108966314438,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,1.17 [0.95-1.44],0.138626963012844,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ACY1,Aminoacylase-1,Inverse variance weighted,6,1.16 [0.95-1.4],0.139756243068138,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SCG3,Secretogranin-3,Inverse variance weighted,16,1.1 [0.97-1.24],0.142021640415918,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL22,Interleukin-22,Inverse variance weighted,4,0.71 [0.45-1.12],0.142206565436746,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.75 [0.5-1.1],0.142632480391054,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Inverse variance weighted,37,1.08 [0.97-1.2],0.144392326245073,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,12,1.12 [0.96-1.31],0.145039013047477,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,1.03 [0.99-1.08],0.147875639847284,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TCN2,Transcobalamin-2,Inverse variance weighted,24,0.96 [0.9-1.02],0.150252202564221,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DSG2,Desmoglein-2,Inverse variance weighted,22,0.92 [0.81-1.03],0.150336247190145,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PRL,Prolactin,Inverse variance weighted,7,0.84 [0.67-1.06],0.150564069998833,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,1.08 [0.97-1.21],0.151268831391574,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VWC2,Brorin,Inverse variance weighted,12,1.18 [0.94-1.47],0.152220001444659,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PTS,6-pyruvoyl tetrahydrobiopterin synthase,Wald ratio,1,0.58 [0.27-1.23],0.152887948408256,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,6,0.79 [0.58-1.09],0.153048513814399,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.86 [0.7-1.06],0.155608851112458,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,17,1.12 [0.96-1.3],0.159220894062335,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.89 [0.76-1.05],0.160679328034363,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Wald ratio,1,0.59 [0.28-1.24],0.161267157907099,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MB,Myoglobin,Inverse variance weighted,9,0.87 [0.72-1.06],0.161792936575408,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,0.86 [0.7-1.06],0.162147990380449,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,1.06 [0.98-1.14],0.163293145817836,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,0.91 [0.79-1.04],0.164240172082202,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1.09 [0.97-1.22],0.164347635719509,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,0.73 [0.46-1.14],0.167941951928653,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,1.23 [0.91-1.67],0.168371358242244,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.23 [0.92-1.64],0.168864577547435,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,50,1.06 [0.98-1.14],0.169726703728311,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HJV,Hemojuvelin,Inverse variance weighted,2,1.42 [0.86-2.33],0.171750468906266,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,1.03 [0.99-1.07],0.172704264030023,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SNCG,Gamma-synuclein,Inverse variance weighted,47,1.03 [0.99-1.08],0.175003731261538,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,56,0.96 [0.9-1.02],0.175922361318933,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NCAN,Neurocan core protein,Inverse variance weighted,19,0.92 [0.81-1.04],0.175983119919782,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFSF12,Tumor necrosis factor ligand superfamily member 12,Inverse variance weighted,20,0.91 [0.8-1.04],0.181054010299082,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL11,Eotaxin,Inverse variance weighted,11,1.07 [0.97-1.18],0.183760007460562,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,0.94 [0.85-1.03],0.184007723980036,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,17,1.04 [0.98-1.09],0.184715317456368,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DPP7,Dipeptidyl peptidase 2,Inverse variance weighted,15,0.96 [0.91-1.02],0.184734076096262,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,19,0.9 [0.78-1.05],0.187289100784731,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MPO,Myeloperoxidase,Inverse variance weighted,17,1.05 [0.98-1.13],0.188772646093265,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,1.25 [0.9-1.73],0.188794747817574,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,13,1.15 [0.93-1.41],0.189931136411088,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BOLA1,BolA-like protein 1,Inverse variance weighted,6,0.87 [0.71-1.07],0.190972857316118,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL17C,Interleukin-17C,Inverse variance weighted,5,1.21 [0.91-1.61],0.191136719919131,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CLEC3B,Tetranectin,Inverse variance weighted,2,1.67 [0.77-3.62],0.194181575244942,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,2,0.65 [0.34-1.24],0.19481645407504,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SLAMF8,SLAM family member 8,Inverse variance weighted,2,0.76 [0.5-1.15],0.194894545432344,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD7,T-cell antigen CD7,Inverse variance weighted,12,1.04 [0.98-1.1],0.195786167765456,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,Inverse variance weighted,2,1.49 [0.81-2.71],0.196594032609251,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SHISA5,Protein shisa-5,Inverse variance weighted,12,1.2 [0.91-1.59],0.197937608104072,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,21,1.08 [0.96-1.22],0.198733730510021,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CAPG,Macrophage-capping protein,Wald ratio,1,0.7 [0.41-1.21],0.204194197367794,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CST1,Cystatin-SN,Inverse variance weighted,12,1.11 [0.94-1.3],0.205938806780251,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.07 [0.96-1.18],0.206281707025608,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.69 [0.39-1.22],0.206287135058863,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.77 [0.51-1.15],0.206821509779008,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TFF1,Trefoil factor 1,Inverse variance weighted,14,1.06 [0.97-1.17],0.207406871025206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,0.87 [0.7-1.08],0.20928078850956,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,OGFR,Opioid growth factor receptor,Inverse variance weighted,2,1.25 [0.88-1.79],0.211171309930798,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.89 [0.74-1.07],0.213424966074748,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,Inverse variance weighted,11,1.28 [0.87-1.89],0.214283142669062,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BRK1,Protein BRICK1,Inverse variance weighted,10,1.08 [0.96-1.23],0.214757105137711,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1.13 [0.93-1.38],0.215898658233343,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,17,0.93 [0.82-1.05],0.216099939642533,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,2,0.78 [0.53-1.15],0.216138588316792,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CRH,Corticoliberin,Inverse variance weighted,55,1.04 [0.98-1.1],0.216327828710209,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,0.86 [0.67-1.09],0.217158929947758,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,0.92 [0.81-1.05],0.218857546396737,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CLC,Galectin-10,Inverse variance weighted,14,1.11 [0.94-1.3],0.223486009826271,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,35,0.95 [0.87-1.03],0.223745542519953,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,9,1.14 [0.92-1.4],0.223995814271611,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,13,1.12 [0.93-1.33],0.225095297319699,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.17 [0.91-1.51],0.225926549950015,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RTBDN,Retbindin,Inverse variance weighted,2,1.34 [0.83-2.16],0.225946378793529,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,1.14 [0.92-1.41],0.226809564073813,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MME,Neprilysin,Inverse variance weighted,46,1.04 [0.98-1.1],0.23001254784668,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TFRC,Transferrin receptor protein 1,Inverse variance weighted,19,0.94 [0.85-1.04],0.23037237364584,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.04 [0.98-1.11],0.230451127877656,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,1.11 [0.93-1.33],0.230881737247169,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,0.8 [0.56-1.15],0.232079061374858,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VEGFD,Vascular endothelial growth factor D,Inverse variance weighted,7,1.1 [0.94-1.28],0.232731215969194,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HEG1,Protein HEG homolog 1,Inverse variance weighted,14,0.89 [0.74-1.08],0.233440253566136,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD34,Hematopoietic progenitor cell antigen CD34,Inverse variance weighted,2,1.52 [0.76-3.05],0.233626948516481,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,6,1.18 [0.9-1.54],0.236005958788254,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CX3CL1,Fractalkine,Inverse variance weighted,12,0.9 [0.76-1.07],0.238903771897511,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,0.89 [0.73-1.08],0.246962513658841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",Inverse variance weighted,2,0.76 [0.47-1.21],0.247480564646403,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PI3,Elafin,Inverse variance weighted,18,1.05 [0.97-1.14],0.247601508619731,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,0.94 [0.85-1.04],0.248754848650339,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,1.16 [0.9-1.5],0.251658471820703,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,1.05 [0.96-1.15],0.251713156371078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,7,1.16 [0.9-1.5],0.252015982466532,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD160,CD160 antigen,Inverse variance weighted,24,1.07 [0.96-1.19],0.253130189437282,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,1.05 [0.97-1.14],0.253249974217001,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,1.06 [0.96-1.18],0.253381061266045,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,1.26 [0.85-1.87],0.255503613337399,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,1.18 [0.89-1.57],0.257801795686183,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ASAH1,Acid ceramidase,Inverse variance weighted,4,0.86 [0.65-1.12],0.258765316727841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,7,0.87 [0.68-1.11],0.259857704718019,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CHGB,Secretogranin-1,Inverse variance weighted,7,1.1 [0.93-1.31],0.259931412409091,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KLK10,Kallikrein-10,Wald ratio,1,0.64 [0.3-1.39],0.26031368525005,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MARCO,Macrophage receptor MARCO,Inverse variance weighted,27,1.08 [0.95-1.23],0.262314026666562,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.59 [0.23-1.49],0.262599831795339,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,9,1.09 [0.93-1.28],0.265118930569171,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,13,0.91 [0.76-1.08],0.267768590306173,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,0.91 [0.78-1.07],0.271233630308663,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,0.92 [0.78-1.07],0.278908139516273,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,STC2,Stanniocalcin-2,Inverse variance weighted,10,0.91 [0.76-1.08],0.279312639085275,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",Inverse variance weighted,4,0.81 [0.55-1.19],0.279599072567865,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,6,1.17 [0.88-1.56],0.280969397798527,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ATOX1,Copper transport protein ATOX1,Wald ratio,1,1.16 [0.89-1.51],0.281079291764194,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PTN,Pleiotrophin,Inverse variance weighted,3,1.19 [0.87-1.63],0.281942004254188,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.11 [0.92-1.34],0.282490468642133,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,0.97 [0.92-1.02],0.283288276959533,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,6,1.14 [0.9-1.46],0.283460833710213,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,0.87 [0.68-1.12],0.283506007663281,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,0.89 [0.73-1.1],0.285703493020556,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1.04 [0.97-1.1],0.286859598928235,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD70,CD70 antigen,Inverse variance weighted,11,1.08 [0.94-1.25],0.287034462293586,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.96 [0.89-1.03],0.2878655012803,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ANG,Angiogenin,Inverse variance weighted,8,0.86 [0.65-1.14],0.28937886996226,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,0.96 [0.88-1.04],0.291186157535378,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,0.94 [0.83-1.06],0.298387982421611,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PCDH7,Protocadherin-7,Inverse variance weighted,3,1.3 [0.79-2.14],0.298965111733816,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VASN,Vasorin,Inverse variance weighted,5,0.83 [0.59-1.18],0.299015414782734,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LBR,Delta(14)-sterol reductase LBR,Inverse variance weighted,2,0.79 [0.5-1.24],0.299914546026209,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,0.9 [0.74-1.1],0.301763777907958,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,Wald ratio,1,0.72 [0.38-1.35],0.301952801210514,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,1.07 [0.94-1.2],0.302243734662382,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,1.11 [0.91-1.36],0.302845698701059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DNMBP,Dynamin-binding protein,Inverse variance weighted,5,1.1 [0.91-1.33],0.303579019583005,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VSTM1,V-set and transmembrane domain-containing protein 1,Inverse variance weighted,3,1.34 [0.77-2.32],0.304456996394325,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CSTB,Cystatin-B,Inverse variance weighted,23,1.04 [0.97-1.11],0.306374330651693,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,0.88 [0.7-1.12],0.306866957982118,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,16,0.91 [0.77-1.09],0.309335863789532,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL4,C-C motif chemokine 4,Inverse variance weighted,37,1.03 [0.97-1.08],0.309451870999778,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,1.18 [0.86-1.63],0.312487952424456,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD302,CD302 antigen,Inverse variance weighted,11,1.08 [0.93-1.25],0.314345068666236,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,JAM3,Junctional adhesion molecule C,Inverse variance weighted,4,1.17 [0.86-1.6],0.315153314423607,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",Inverse variance weighted,17,1.04 [0.96-1.13],0.315425338135658,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,OSM,Oncostatin-M,Inverse variance weighted,6,1.1 [0.91-1.34],0.319771753825029,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,11,0.94 [0.82-1.07],0.321583209238596,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PYY,Peptide YY,Inverse variance weighted,16,0.95 [0.86-1.05],0.322544423744255,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,17,0.92 [0.78-1.08],0.322752284477584,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,1.05 [0.95-1.16],0.322914996451892,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",Wald ratio,1,1.7 [0.59-4.9],0.325150311938229,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PPL,Periplakin,Inverse variance weighted,2,1.21 [0.82-1.78],0.329630898097412,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PSAP,Prosaposin,Inverse variance weighted,13,0.95 [0.86-1.05],0.329769181844219,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,1.09 [0.91-1.31],0.329849506226593,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SEZ6L,Seizure 6-like protein,Inverse variance weighted,10,0.89 [0.71-1.12],0.330615699416892,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,1.2 [0.83-1.72],0.331808072975548,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PRELP,Prolargin,Inverse variance weighted,5,1.24 [0.8-1.94],0.332388927354272,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,1.08 [0.92-1.27],0.335422159878064,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,AHNAK2,Protein AHNAK2,Inverse variance weighted,3,1.22 [0.81-1.85],0.336483086434516,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,0.92 [0.79-1.09],0.336537327347565,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GUCA2A,Guanylin,Inverse variance weighted,7,0.89 [0.71-1.13],0.338061200512162,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,1.1 [0.9-1.34],0.338083928107902,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DPT,Dermatopontin,Inverse variance weighted,4,1.19 [0.83-1.69],0.338489256108962,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,17,0.94 [0.82-1.07],0.33910872318733,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,6,0.88 [0.68-1.14],0.340100871378913,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MSLN,Mesothelin,Inverse variance weighted,11,1.09 [0.91-1.31],0.341106450062845,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GFAP,Glial fibrillary acidic protein,Inverse variance weighted,14,0.94 [0.82-1.07],0.341178938064289,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1.08 [0.92-1.27],0.342375463233669,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1.05 [0.94-1.18],0.344699088318247,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CA6,Carbonic anhydrase 6,Inverse variance weighted,21,1.12 [0.89-1.41],0.345385888744764,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,1.17 [0.84-1.63],0.346609374313956,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,7,1.16 [0.85-1.58],0.34661148526373,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.19 [0.83-1.71],0.347116845409192,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FLT1,Vascular endothelial growth factor receptor 1,Inverse variance weighted,16,1.05 [0.95-1.16],0.34764392235806,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FBLN2,Fibulin-2,Inverse variance weighted,6,1.11 [0.89-1.38],0.348093090797681,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.12 [0.89-1.41],0.348480225128199,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,1.02 [0.97-1.08],0.348581884460235,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KLKB1,Plasma kallikrein,Inverse variance weighted,20,0.95 [0.85-1.06],0.3493535002797,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CTSS,Cathepsin S,Inverse variance weighted,7,0.9 [0.73-1.12],0.353211975838242,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,19,0.97 [0.9-1.04],0.35402089216935,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL28,C-C motif chemokine 28,Inverse variance weighted,30,1.04 [0.95-1.14],0.354444760058323,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1.07 [0.93-1.23],0.354741469263888,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,F11R,Junctional adhesion molecule A,Inverse variance weighted,3,0.86 [0.62-1.19],0.355762569836687,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.33 [0.73-2.42],0.355967344385967,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GLA,Alpha-galactosidase A,Inverse variance weighted,2,0.85 [0.6-1.2],0.35690997154293,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL1RL2,Interleukin-1 receptor-like 2,Inverse variance weighted,27,0.95 [0.85-1.06],0.357256272323945,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ALCAM,CD166 antigen,Inverse variance weighted,4,0.91 [0.75-1.11],0.357269350931137,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",Inverse variance weighted,4,0.86 [0.63-1.18],0.359474332790895,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SIAE,Sialate O-acetylesterase,Inverse variance weighted,6,0.89 [0.7-1.14],0.360894805184426,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CKB,Creatine kinase B-type,Inverse variance weighted,11,1.15 [0.86-1.53],0.362235949306269,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,19,1.04 [0.96-1.12],0.362491591816254,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DEFB4A_DEFB4B,Beta-defensin 4A,Inverse variance weighted,7,1.16 [0.84-1.59],0.363455242739468,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LCN15,Lipocalin-15,Inverse variance weighted,22,0.98 [0.92-1.03],0.366026309812088,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,1.14 [0.86-1.5],0.368690336095509,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,1.14 [0.86-1.51],0.368759189871105,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.24 [0.77-2],0.368836061644605,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",Inverse variance weighted,4,0.84 [0.57-1.23],0.369906379469757,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,7,0.92 [0.77-1.1],0.3700004117167,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CDH1,Cadherin-1,Inverse variance weighted,16,0.95 [0.86-1.06],0.370172847862492,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CTSF,Cathepsin F,Inverse variance weighted,27,0.96 [0.89-1.05],0.370738294027713,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,5,1.16 [0.83-1.63],0.371113349687942,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CDH3,Cadherin-3,Inverse variance weighted,10,1.1 [0.89-1.35],0.371284554108345,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,Inverse variance weighted,17,1.05 [0.94-1.18],0.371393564962535,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BSG,Basigin,Inverse variance weighted,6,0.89 [0.69-1.15],0.373361013684498,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,UNC5D,Netrin receptor UNC5D,Wald ratio,1,0.69 [0.31-1.56],0.376184257901016,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,1.02 [0.97-1.08],0.378031914217442,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,16,0.93 [0.8-1.09],0.378954794028158,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,0.87 [0.65-1.18],0.379737692096876,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,13,0.95 [0.83-1.07],0.381752922733416,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,2,1.17 [0.82-1.68],0.38292730142025,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,28,0.96 [0.87-1.06],0.38323055862099,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,XCL1,Lymphotactin,Inverse variance weighted,15,1.08 [0.91-1.28],0.385998643433106,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,0.85 [0.6-1.22],0.387128485332668,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MILR1,Allergin-1,Inverse variance weighted,43,0.99 [0.95-1.02],0.389261191998225,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL10,Interleukin-10,Inverse variance weighted,4,1.06 [0.93-1.2],0.389793250752533,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CTSE,Cathepsin E,Inverse variance weighted,8,0.9 [0.71-1.14],0.389814014706961,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MSTN,Growth/differentiation factor 8,Inverse variance weighted,11,0.89 [0.69-1.16],0.389904574488461,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SEMA7A,Semaphorin-7A,Inverse variance weighted,20,0.96 [0.86-1.06],0.392258618632779,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1.03 [0.97-1.09],0.392841785349034,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,1.1 [0.88-1.38],0.392861840658365,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CSRP3,Cysteine and glycine-rich protein 3,Inverse variance weighted,3,1.15 [0.83-1.6],0.395163535604892,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FOLR1,Folate receptor alpha,Inverse variance weighted,6,0.8 [0.47-1.34],0.395392615769074,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PRSS27,Serine protease 27,Inverse variance weighted,47,1.03 [0.97-1.09],0.395608556212233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CLSTN2,Calsyntenin-2,Inverse variance weighted,8,1.1 [0.88-1.36],0.397264198599384,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,5,0.83 [0.55-1.27],0.398405619130098,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,28,0.98 [0.93-1.03],0.402102950512874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FDX1,"Adrenodoxin, mitochondrial",Wald ratio,1,1.34 [0.68-2.63],0.403241803664038,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNC,Tenascin,Inverse variance weighted,57,1.02 [0.97-1.08],0.403398124651974,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,1.09 [0.89-1.34],0.404204196091823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.91 [0.73-1.13],0.404511546317,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,1.13 [0.84-1.53],0.405076908654878,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ITGAM,Integrin alpha-M,Inverse variance weighted,12,0.94 [0.81-1.09],0.406040521654854,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CXCL8,Interleukin-8,Inverse variance weighted,8,0.94 [0.8-1.1],0.407069438299081,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CRLF1,Cytokine receptor-like factor 1,Inverse variance weighted,15,0.94 [0.8-1.1],0.409844253412512,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LEP,Leptin,Inverse variance weighted,4,0.84 [0.56-1.27],0.410933605298222,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ALPP,"Alkaline phosphatase, placental type",Inverse variance weighted,21,0.95 [0.83-1.08],0.412887559155373,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,1.11 [0.86-1.42],0.413496818437624,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.18 [0.79-1.75],0.416909893589064,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MSMB,Beta-microseminoprotein,Inverse variance weighted,52,0.99 [0.95-1.02],0.417329399337742,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,0.93 [0.78-1.11],0.418896995219973,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1.05 [0.94-1.17],0.421597999075491,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,0.77 [0.4-1.46],0.422395635663767,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CNTNAP2,Contactin-associated protein-like 2,Inverse variance weighted,11,0.93 [0.78-1.11],0.422610192279408,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,1.04 [0.95-1.13],0.42304624957842,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DSG3,Desmoglein-3,Inverse variance weighted,27,1.03 [0.96-1.11],0.423208753335305,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NECTIN2,Nectin-2,Inverse variance weighted,3,0.82 [0.51-1.32],0.423683558479538,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TIMP2,Metalloproteinase inhibitor 2,Inverse variance weighted,3,1.1 [0.86-1.41],0.426485401833666,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.17 [0.8-1.7],0.426505381562774,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,17,0.94 [0.82-1.09],0.431546751716292,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MEP1B,Meprin A subunit beta,Inverse variance weighted,72,0.99 [0.96-1.02],0.43202892030101,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,11,1.08 [0.9-1.29],0.432290027109072,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,0.84 [0.54-1.3],0.432372836151485,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,11,1.05 [0.93-1.19],0.433086022467872,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,15,0.96 [0.85-1.07],0.434376834641015,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CFC1,Cryptic protein,Inverse variance weighted,11,0.91 [0.73-1.15],0.434705790103541,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,2,1.25 [0.72-2.17],0.436967531611328,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,6,1.13 [0.83-1.52],0.437441520608856,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,0.91 [0.71-1.16],0.437674834970011,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.11 [0.85-1.45],0.437883336645231,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,POSTN,Periostin,Inverse variance weighted,14,1.03 [0.95-1.12],0.439671014309532,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EFNB2,Ephrin-B2,Wald ratio,1,0.93 [0.77-1.12],0.440623472011536,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,0.91 [0.7-1.17],0.443520417375723,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,1.07 [0.89-1.29],0.443907631574615,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,1.06 [0.91-1.23],0.444180898482228,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NPTX2,Neuronal pentraxin-2,Inverse variance weighted,7,1.11 [0.85-1.46],0.444252123083016,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MMP10,Stromelysin-2,Wald ratio,1,0.75 [0.36-1.57],0.444252898394981,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PKD1,Polycystin-1,Inverse variance weighted,12,0.92 [0.75-1.13],0.444317390568837,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RCC1,Regulator of chromosome condensation,Wald ratio,1,1.29 [0.67-2.49],0.444433730721813,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCN4,CCN family member 4,Inverse variance weighted,29,0.97 [0.9-1.05],0.446894476954726,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CTSZ,Cathepsin Z,Inverse variance weighted,16,0.97 [0.91-1.04],0.448746284149787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,1.08 [0.88-1.32],0.452349464690788,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,4,1.09 [0.87-1.35],0.452549898231259,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SLAMF7,SLAM family member 7,Inverse variance weighted,16,0.95 [0.84-1.08],0.455500158794433,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TALDO1,Transaldolase,Wald ratio,1,0.57 [0.13-2.48],0.455689261283967,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MVK,Mevalonate kinase,Wald ratio,1,0.57 [0.13-2.5],0.455689261283967,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,2,0.84 [0.53-1.33],0.456495633064089,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.21 [0.73-2],0.458210170391604,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,1.02 [0.96-1.09],0.462964436804615,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CLSTN3,Calsyntenin-3,Inverse variance weighted,7,1.08 [0.88-1.34],0.463465705844271,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ACTN2,Alpha-actinin-2,Inverse variance weighted,4,1.09 [0.85-1.4],0.473928483757976,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FUS,RNA-binding protein FUS,Wald ratio,1,1.26 [0.67-2.36],0.474502887401062,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,8,1.08 [0.87-1.33],0.477739417291331,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FCRLB,Fc receptor-like B,Inverse variance weighted,10,1.07 [0.89-1.27],0.478654310391719,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ABL1,Tyrosine-protein kinase ABL1,Inverse variance weighted,3,1.17 [0.75-1.82],0.483438508680555,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD48,CD48 antigen,Inverse variance weighted,14,0.93 [0.75-1.15],0.484521315622043,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RBP7,Retinoid-binding protein 7,Inverse variance weighted,5,1.11 [0.82-1.51],0.485235696952625,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SPP1,Osteopontin,Inverse variance weighted,13,1.08 [0.87-1.36],0.485725482172189,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.1 [0.84-1.42],0.487283407432424,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,25,1.06 [0.91-1.23],0.487498496267608,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GCG,Pro-glucagon,Inverse variance weighted,2,0.84 [0.52-1.37],0.489343559145748,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CALB1,Calbindin,Inverse variance weighted,9,0.93 [0.75-1.15],0.491395818053339,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SCPEP1,Retinoid-inducible serine carboxypeptidase,Inverse variance weighted,12,0.93 [0.76-1.14],0.494559047414074,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,Wald ratio,1,0.56 [0.1-2.99],0.49587899728136,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,14,0.94 [0.79-1.12],0.495954996668667,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,0.92 [0.73-1.16],0.49654175891389,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CYB5R2,NADH-cytochrome b5 reductase 2,Inverse variance weighted,2,1.18 [0.73-1.92],0.502888449983553,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,0.99 [0.95-1.03],0.503123121935639,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,0.81 [0.44-1.5],0.505138415516371,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NXPH3,Neurexophilin-3,Inverse variance weighted,19,1.03 [0.94-1.14],0.505335641507573,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.03 [0.95-1.12],0.506394158616598,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VIT,Vitrin,Inverse variance weighted,10,0.94 [0.78-1.13],0.506728696256594,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SDC4,Syndecan-4,Inverse variance weighted,35,0.97 [0.9-1.06],0.507634635000595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,1.07 [0.87-1.31],0.507912706688971,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NID1,Nidogen-1,Inverse variance weighted,6,0.95 [0.81-1.11],0.508536798250207,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,3,0.8 [0.41-1.55],0.50981613009008,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.78 [0.38-1.62],0.510051664610221,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,11,0.98 [0.93-1.04],0.512062058133052,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SCGB3A1,Secretoglobin family 3A member 1,Inverse variance weighted,26,0.96 [0.87-1.07],0.512773526608442,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.04 [0.93-1.16],0.513729977648541,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,Inverse variance weighted,2,1.15 [0.76-1.74],0.514095198696421,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,Wald ratio,1,1.42 [0.49-4.09],0.514914624080587,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,Inverse variance weighted,12,0.91 [0.68-1.22],0.515173134247699,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,13,0.95 [0.81-1.11],0.516288665690269,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,AKR7L,Aflatoxin B1 aldehyde reductase member 4,Wald ratio,1,1.15 [0.75-1.76],0.519314232347948,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,F3,Tissue factor,Inverse variance weighted,13,0.91 [0.68-1.22],0.520609595803811,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,Inverse variance weighted,2,0.86 [0.54-1.36],0.521162521357052,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LMNB2,Lamin-B2,Inverse variance weighted,8,1.08 [0.86-1.35],0.523205368198902,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.39 [0.5-3.89],0.526444935245095,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,0.97 [0.89-1.06],0.526678188021072,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PLIN1,Perilipin-1,Wald ratio,1,0.82 [0.44-1.52],0.527670019025872,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,8,1.05 [0.89-1.25],0.52794566157105,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ITGA11,Integrin alpha-11,Inverse variance weighted,7,0.93 [0.75-1.16],0.529021692614016,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,1.09 [0.84-1.42],0.529876828441253,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,Inverse variance weighted,33,0.98 [0.94-1.03],0.531290200859916,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,1.05 [0.9-1.22],0.532297138615475,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,14,1.06 [0.89-1.26],0.532873849261868,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,Inverse variance weighted,11,1.04 [0.93-1.16],0.533801575540957,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Inverse variance weighted,19,1.03 [0.94-1.12],0.534962102607866,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,1.03 [0.94-1.12],0.535073457163285,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,1.12 [0.78-1.61],0.53560524926081,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,0.96 [0.86-1.08],0.537660294585876,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NUCB2,Nucleobindin-2,Inverse variance weighted,2,0.86 [0.54-1.38],0.539217575274196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,29,1.03 [0.93-1.15],0.540505604473807,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SPON1,Spondin-1,Inverse variance weighted,4,1.1 [0.81-1.48],0.541088524003654,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,Inverse variance weighted,48,0.98 [0.93-1.04],0.54128877146768,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNR,Tenascin-R,Inverse variance weighted,19,0.97 [0.87-1.07],0.541861531552441,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GSN,Gelsolin,Inverse variance weighted,7,1.06 [0.87-1.3],0.543009438342119,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,1.1 [0.8-1.52],0.544232135869849,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.92 [0.72-1.19],0.545322428870608,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,1.02 [0.95-1.1],0.545428189605882,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,1.05 [0.89-1.24],0.546439105304062,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.84 [0.47-1.5],0.548405449332145,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,1.1 [0.81-1.5],0.548660252454462,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SPRR3,Small proline-rich protein 3,Inverse variance weighted,6,0.93 [0.75-1.17],0.548763090877452,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LGALS4,Galectin-4,Inverse variance weighted,15,0.97 [0.9-1.06],0.549340273348107,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DBI,Acyl-CoA-binding protein,Wald ratio,1,1.13 [0.76-1.67],0.5515074525067,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADGRE1,Adhesion G protein-coupled receptor E1,Inverse variance weighted,22,1.03 [0.93-1.15],0.552294486365104,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,17,1.04 [0.91-1.18],0.552920625312013,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CPM,Carboxypeptidase M,Inverse variance weighted,19,0.95 [0.8-1.13],0.553107091067845,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.04 [0.9-1.21],0.553797376013691,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCN3,CCN family member 3,Inverse variance weighted,17,1.03 [0.93-1.15],0.55388127605014,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,1.09 [0.81-1.48],0.554045362511478,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,5,0.94 [0.77-1.15],0.556910113801245,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GBP1,Guanylate-binding protein 1,Inverse variance weighted,4,0.94 [0.76-1.16],0.557627908823051,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FAM3C,Protein FAM3C,Inverse variance weighted,3,0.87 [0.55-1.38],0.557845895743368,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,1.25 [0.6-2.6],0.559204448657778,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,7,1.07 [0.84-1.37],0.559557307520974,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,1.11 [0.78-1.6],0.56014980638658,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CTSL,Cathepsin L1,Inverse variance weighted,29,0.97 [0.87-1.08],0.560384490336503,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.95 [0.79-1.14],0.561091597713572,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,1.03 [0.93-1.14],0.562520243966621,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,54,1.01 [0.97-1.05],0.562910342187399,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,1.28 [0.55-2.97],0.563256747832512,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,0.92 [0.71-1.21],0.56329410952589,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,0.93 [0.74-1.18],0.564106900226862,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADA,Adenosine deaminase,Inverse variance weighted,22,0.99 [0.94-1.03],0.567713109097284,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SELENOP,Selenoprotein P,Inverse variance weighted,3,1.13 [0.74-1.74],0.567865479821407,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,12,1.04 [0.91-1.18],0.56948516325299,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,4,1.06 [0.87-1.3],0.571967293159997,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,19,0.97 [0.86-1.09],0.572558197526456,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,1.13 [0.73-1.76],0.572962551300039,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,11,1.04 [0.9-1.2],0.574556617344002,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PCDHB15,Protocadherin beta-15,Inverse variance weighted,19,1.03 [0.93-1.13],0.575554489816615,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SPINK6,Serine protease inhibitor Kazal-type 6,Wald ratio,1,1.22 [0.61-2.41],0.575941861924361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.87 [0.52-1.44],0.579859094733391,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PLXNB2,Plexin-B2,Inverse variance weighted,12,0.95 [0.79-1.14],0.580388357028143,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,8,1.07 [0.84-1.35],0.584279561240383,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,6,1.12 [0.74-1.7],0.585418435700301,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FAM3B,Protein FAM3B,Inverse variance weighted,26,0.98 [0.93-1.04],0.58544178584169,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GABARAP,Gamma-aminobutyric acid receptor-associated protein,Inverse variance weighted,4,0.92 [0.68-1.25],0.585863387555263,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,1.06 [0.85-1.33],0.586171748156284,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CHGA,Chromogranin-A,Inverse variance weighted,5,1.11 [0.76-1.63],0.587319040864099,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.07 [0.84-1.35],0.589746654365791,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.98 [0.91-1.05],0.593277679574608,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,5,1.03 [0.93-1.13],0.593921112760784,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FGA,Fibrinogen alpha chain,Inverse variance weighted,6,0.93 [0.71-1.22],0.59695837033992,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PLB1,"Phospholipase B1, membrane-associated",Inverse variance weighted,30,0.97 [0.86-1.09],0.597675132534212,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,0.83 [0.41-1.68],0.597894602069377,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ELN,Elastin,Inverse variance weighted,10,1.05 [0.86-1.29],0.597941114674382,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,OMG,Oligodendrocyte-myelin glycoprotein,Inverse variance weighted,15,0.96 [0.84-1.11],0.599204876329621,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CDH2,Cadherin-2,Inverse variance weighted,21,1.03 [0.92-1.15],0.599719574917593,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,0.88 [0.55-1.42],0.601262753447975,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.07 [0.83-1.36],0.60468753278039,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ITGAV,Integrin alpha-V,Inverse variance weighted,10,0.94 [0.73-1.2],0.604755706036566,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,11,0.96 [0.81-1.13],0.605361116258927,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GOLM2,Protein GOLM2,Inverse variance weighted,14,1.03 [0.92-1.15],0.60557513821677,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,1.07 [0.83-1.39],0.606194296826241,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,0.95 [0.79-1.14],0.606456571542176,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,0.89 [0.57-1.39],0.607047979770334,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PAXX,Protein PAXX,Wald ratio,1,1.09 [0.78-1.51],0.609137990635126,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,0.83 [0.41-1.68],0.61020354938711,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.01 [0.97-1.05],0.6105785122042,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.05 [0.86-1.29],0.611413840206727,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,0.93 [0.7-1.23],0.611912576198376,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,UMOD,Uromodulin,Inverse variance weighted,34,1.03 [0.91-1.18],0.613707659453159,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MYL3,Myosin light chain 3,Inverse variance weighted,13,0.96 [0.81-1.13],0.613896346327183,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,20,0.97 [0.84-1.11],0.616124665386304,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.97 [0.84-1.11],0.616895875857793,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,32,0.97 [0.88-1.08],0.617942416792213,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NUDT5,ADP-sugar pyrophosphatase,Wald ratio,1,1.18 [0.62-2.24],0.619057034026629,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.03 [0.92-1.15],0.621263139453677,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CTSO,Cathepsin O,Inverse variance weighted,19,0.98 [0.9-1.07],0.621826351451485,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL18,C-C motif chemokine 18,Inverse variance weighted,19,1.01 [0.96-1.07],0.62188542107764,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,1.11 [0.72-1.71],0.628657553932365,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CTSD,Cathepsin D,Inverse variance weighted,7,0.94 [0.74-1.2],0.629566460344782,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SPON2,Spondin-2,Inverse variance weighted,3,0.91 [0.61-1.35],0.629747527417891,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,0.98 [0.9-1.06],0.6302370343908,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,27,0.98 [0.9-1.06],0.63105491352871,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,14,0.95 [0.76-1.18],0.631743106686032,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,4,0.88 [0.52-1.48],0.633607640753273,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.04 [0.89-1.2],0.633775373591564,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ANPEP,Aminopeptidase N,Inverse variance weighted,2,0.85 [0.44-1.64],0.634559323130977,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BAP18,Chromatin complexes subunit BAP18,Wald ratio,1,0.86 [0.45-1.62],0.635161449083025,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BMP10,Bone morphogenetic protein 10,Inverse variance weighted,19,1.03 [0.91-1.17],0.637654354738491,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,0.96 [0.82-1.13],0.638944160730522,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Inverse variance weighted,27,0.98 [0.88-1.08],0.639519044141577,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,11,0.97 [0.84-1.11],0.639608186821079,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL5RA,Interleukin-5 receptor subunit alpha,Inverse variance weighted,38,0.98 [0.88-1.08],0.639853045641042,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,7,0.93 [0.7-1.25],0.641406528927819,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RSPO3,R-spondin-3,Inverse variance weighted,5,0.94 [0.73-1.21],0.642310223924185,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,11,0.95 [0.76-1.18],0.642767828164924,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LAMB1,Laminin subunit beta-1,Inverse variance weighted,21,0.98 [0.89-1.07],0.644370368032891,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,B2M,Beta-2-microglobulin,Inverse variance weighted,7,0.9 [0.57-1.41],0.645680514673501,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,1.02 [0.94-1.11],0.646485428530197,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,0.96 [0.82-1.13],0.648246503459563,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HGF,Hepatocyte growth factor,Inverse variance weighted,5,1.07 [0.79-1.46],0.648830878461427,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LUZP2,Leucine zipper protein 2,Wald ratio,1,0.84 [0.41-1.75],0.648897641056977,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PTP4A3,Protein tyrosine phosphatase type IVA 3,Inverse variance weighted,6,0.97 [0.86-1.1],0.65012956033617,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,0.88 [0.5-1.55],0.652125127977673,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,S100A11,Protein S100-A11,Wald ratio,1,1.14 [0.65-1.98],0.653372157172537,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NPL,N-acetylneuraminate lyase,Inverse variance weighted,5,0.93 [0.68-1.27],0.653782824456565,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,9,1.05 [0.84-1.31],0.653875496989415,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,0.95 [0.76-1.19],0.654064248604121,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL6,Interleukin-6,Inverse variance weighted,6,1.03 [0.91-1.17],0.658001079154137,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DCTPP1,dCTP pyrophosphatase 1,Inverse variance weighted,5,1.08 [0.76-1.54],0.658359417233113,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,Inverse variance weighted,4,1.08 [0.77-1.51],0.659199294428044,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,Wald ratio,1,0.86 [0.44-1.68],0.660288271075755,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,THBS2,Thrombospondin-2,Inverse variance weighted,15,0.96 [0.82-1.14],0.66058998184184,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,1.07 [0.8-1.43],0.6619076914893,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,0.97 [0.83-1.13],0.662565354660284,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,AREG,Amphiregulin,Inverse variance weighted,5,0.94 [0.73-1.23],0.663618592344843,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,4,0.95 [0.76-1.19],0.66557571124956,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,0.98 [0.9-1.07],0.666835588653425,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ICAM3,Intercellular adhesion molecule 3,Inverse variance weighted,22,1.02 [0.93-1.11],0.666921469661594,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL18,Interleukin-18,Inverse variance weighted,26,0.98 [0.91-1.06],0.667628203903675,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,0.98 [0.88-1.09],0.668835510228145,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,1.07 [0.77-1.49],0.673951978254719,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SCGB3A2,Secretoglobin family 3A member 2,Inverse variance weighted,27,1.02 [0.93-1.12],0.674416842897466,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IDUA,Alpha-L-iduronidase,Inverse variance weighted,18,0.95 [0.77-1.19],0.675465001988366,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SPARCL1,SPARC-like protein 1,Inverse variance weighted,21,1.03 [0.91-1.15],0.676074385396301,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.89 [0.52-1.52],0.676162655936003,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,28,0.98 [0.91-1.06],0.67732994636051,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CTSV,Cathepsin L2,Inverse variance weighted,34,1.02 [0.94-1.1],0.680872777584233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,12,0.97 [0.81-1.14],0.681020386363376,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,POF1B,Protein POF1B,Inverse variance weighted,4,0.94 [0.72-1.24],0.681200823429106,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,7,1.07 [0.78-1.45],0.683051281368747,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,1.05 [0.82-1.34],0.683664106803385,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NECTIN4,Nectin-4,Inverse variance weighted,4,1.07 [0.77-1.5],0.684039430239996,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SUOX,"Sulfite oxidase, mitochondrial",Inverse variance weighted,8,0.97 [0.84-1.12],0.685059271134351,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,27,0.99 [0.94-1.04],0.686682360088005,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,1.01 [0.95-1.08],0.687803228626977,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IFNL1,Interferon lambda-1,Inverse variance weighted,8,0.97 [0.82-1.14],0.687928147988842,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,0.98 [0.88-1.09],0.687959253763758,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DSC2,Desmocollin-2,Inverse variance weighted,16,1.02 [0.93-1.11],0.688671968225094,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PALM2,Paralemmin-2,Inverse variance weighted,9,1.02 [0.91-1.15],0.690357108211213,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD276,CD276 antigen,Inverse variance weighted,24,0.98 [0.88-1.09],0.691158365932443,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,13,0.97 [0.83-1.13],0.691582932703448,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DPP10,Inactive dipeptidyl peptidase 10,Inverse variance weighted,24,1.02 [0.94-1.1],0.693630579230511,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,0.97 [0.81-1.15],0.694528150967857,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL32,Interleukin-32,Inverse variance weighted,9,0.97 [0.82-1.15],0.695534782774992,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.96 [0.76-1.2],0.696995980712718,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GAST,Gastrin,Inverse variance weighted,9,1.04 [0.86-1.25],0.698719752985232,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,15,0.97 [0.84-1.13],0.698856721446372,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GPR15L,Protein GPR15L,Inverse variance weighted,13,0.98 [0.9-1.07],0.699801738631183,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ITGA5,Integrin alpha-5,Inverse variance weighted,18,1.02 [0.91-1.16],0.701046183606402,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,21,1.02 [0.94-1.1],0.703182521328727,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IMMT,MICOS complex subunit MIC60,Wald ratio,1,1.1 [0.67-1.82],0.705009186038201,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MATN2,Matrilin-2,Inverse variance weighted,28,1.01 [0.94-1.09],0.705083538065553,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,15,0.98 [0.87-1.1],0.70635854176202,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,5,0.93 [0.66-1.33],0.708057650092101,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ENDOU,Poly(U)-specific endoribonuclease,Inverse variance weighted,22,1.02 [0.91-1.15],0.708354962849623,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,1.01 [0.95-1.08],0.709082708864478,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.85 [0.36-2.01],0.710571732108916,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CALCA,Calcitonin,Inverse variance weighted,13,0.97 [0.81-1.16],0.710908600184021,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,XG,Glycoprotein Xg,Inverse variance weighted,2,0.9 [0.51-1.59],0.711685848791716,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,11,1.05 [0.82-1.33],0.713592062747457,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,5,0.96 [0.77-1.19],0.713982595524413,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,16,1.03 [0.87-1.23],0.719677415955937,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,1.05 [0.81-1.36],0.720664282370368,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.97 [0.83-1.13],0.721742816368472,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.04 [0.85-1.27],0.721750765055256,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,Inverse variance weighted,5,1.07 [0.72-1.6],0.723034067378081,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,18,1.02 [0.9-1.16],0.723627911699285,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,COL3A1,Collagen alpha-1(III) chain,Inverse variance weighted,5,0.96 [0.75-1.22],0.725793869207231,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.12 [0.58-2.16],0.7266538294936,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,57,1.01 [0.96-1.05],0.727069947917394,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FABP6,Gastrotropin,Inverse variance weighted,4,1.06 [0.77-1.47],0.727302682122925,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,0.97 [0.82-1.15],0.732183851168011,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GPC5,Glypican-5,Inverse variance weighted,42,0.99 [0.94-1.05],0.732932286332913,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FCRL2,Fc receptor-like protein 2,Inverse variance weighted,30,1.02 [0.92-1.13],0.736389918955448,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,14,0.96 [0.76-1.21],0.737244886024259,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,1.02 [0.9-1.16],0.738994932830961,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",Wald ratio,1,0.89 [0.45-1.77],0.739732535251516,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,0.94 [0.64-1.38],0.74044658125167,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DKK3,Dickkopf-related protein 3,Inverse variance weighted,14,1.02 [0.92-1.12],0.740816875322762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.01 [0.95-1.07],0.741433100381173,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,5,0.95 [0.7-1.29],0.741816665318406,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,0.98 [0.89-1.09],0.742395463805404,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MFGE8,Lactadherin,Inverse variance weighted,15,0.97 [0.84-1.14],0.742535977268314,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KLK11,Kallikrein-11,Inverse variance weighted,13,1.03 [0.88-1.2],0.742607267970065,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,Wald ratio,1,1.11 [0.6-2.04],0.743323422280623,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CPA4,Carboxypeptidase A4,Inverse variance weighted,9,1.04 [0.82-1.32],0.745321749638291,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL22,C-C motif chemokine 22,Inverse variance weighted,8,0.96 [0.77-1.21],0.74602269405618,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,0.98 [0.87-1.11],0.746775406285832,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,Inverse variance weighted,3,0.93 [0.59-1.47],0.747383601086235,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LGALS3,Galectin-3,Inverse variance weighted,15,1.02 [0.89-1.17],0.749433130437778,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,Inverse variance weighted,33,0.99 [0.93-1.05],0.749970307322731,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,1.05 [0.78-1.4],0.751660580546816,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SERPINA5,Plasma serine protease inhibitor,Inverse variance weighted,7,0.98 [0.86-1.12],0.753772148261356,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MUC13,Mucin-13,Inverse variance weighted,3,0.92 [0.54-1.56],0.754383001794297,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RSPO1,R-spondin-1,Inverse variance weighted,8,0.97 [0.83-1.15],0.754601416810774,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,4,0.94 [0.64-1.38],0.75460687641399,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,1.02 [0.89-1.18],0.754683942431451,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,P4HB,Protein disulfide-isomerase,Inverse variance weighted,4,0.94 [0.62-1.41],0.754702327664887,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.03 [0.85-1.25],0.756355538281519,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.97 [0.81-1.16],0.756976421890854,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,OGN,Mimecan,Inverse variance weighted,37,1.01 [0.95-1.07],0.759871383630506,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,1.02 [0.89-1.17],0.760036669510358,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.98 [0.84-1.14],0.761463380559643,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,1.02 [0.89-1.17],0.761654432546479,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KLK4,Kallikrein-4,Inverse variance weighted,5,1.06 [0.73-1.53],0.76316930458142,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,17,0.98 [0.85-1.13],0.764305503081149,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SERPINA11,Serpin A11,Inverse variance weighted,14,0.97 [0.78-1.2],0.767239433289419,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MMP1,Interstitial collagenase,Inverse variance weighted,14,0.98 [0.85-1.12],0.767791629375294,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,Inverse variance weighted,11,0.97 [0.78-1.2],0.76792157503401,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.08 [0.64-1.84],0.769886661493736,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,0.95 [0.69-1.31],0.770489279468045,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.95 [0.67-1.34],0.770738234612973,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,3,1.05 [0.75-1.48],0.772477126778612,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,30,0.99 [0.92-1.07],0.772892474928512,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.02 [0.88-1.19],0.773944956591699,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.97 [0.81-1.17],0.774171388269633,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,INHBB,Inhibin beta B chain,Inverse variance weighted,11,0.97 [0.79-1.19],0.774344854271246,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD55,Complement decay-accelerating factor,Inverse variance weighted,8,0.97 [0.76-1.22],0.774813810106387,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GPKOW,G-patch domain and KOW motifs-containing protein,Inverse variance weighted,2,0.93 [0.56-1.55],0.775814438581861,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CNTN5,Contactin-5,Inverse variance weighted,22,0.98 [0.87-1.11],0.775832038730183,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,1.05 [0.77-1.42],0.777077877631852,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.03 [0.83-1.28],0.777194365955915,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,6,1.03 [0.82-1.31],0.777680495788673,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,22,0.99 [0.89-1.09],0.779017286236067,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RGMB,RGM domain family member B,Inverse variance weighted,5,1.07 [0.68-1.67],0.781422180732391,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,1.05 [0.73-1.51],0.781510677508219,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PRTN3,Myeloblastin,Inverse variance weighted,20,1.02 [0.91-1.13],0.781542826910378,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,0.96 [0.71-1.3],0.78274984986545,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,1.1 [0.56-2.15],0.782992894810364,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,1.1 [0.55-2.19],0.784938184987089,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,0.96 [0.7-1.31],0.78554914579128,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,APOA4,Apolipoprotein A-IV,Inverse variance weighted,4,0.95 [0.66-1.37],0.786346652767131,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,1.04 [0.8-1.34],0.786445402951664,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FASLG,Tumor necrosis factor ligand superfamily member 6,Inverse variance weighted,53,1.01 [0.94-1.09],0.786464055483138,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SDC1,Syndecan-1,Inverse variance weighted,12,0.98 [0.85-1.13],0.788295069135976,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,0.91 [0.44-1.86],0.788328394630143,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LAYN,Layilin,Inverse variance weighted,3,1.1 [0.56-2.15],0.789297331363533,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,1.01 [0.91-1.13],0.790813849561047,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MMP3,Stromelysin-1,Inverse variance weighted,4,0.94 [0.61-1.45],0.791040096521071,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.9 [0.39-2.05],0.793044450173952,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NRP1,Neuropilin-1,Inverse variance weighted,14,1.02 [0.86-1.22],0.793229318479551,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,33,0.99 [0.93-1.05],0.793459171046067,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,0.97 [0.75-1.24],0.795688289220182,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1.01 [0.94-1.08],0.795781049385072,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PRSS2,Trypsin-2,Inverse variance weighted,17,0.98 [0.85-1.13],0.795949667284606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.03 [0.83-1.27],0.796419872249885,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,1.07 [0.64-1.8],0.798043550275595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.04 [0.75-1.46],0.799408581080635,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,Inverse variance weighted,4,1.04 [0.76-1.42],0.799502855413522,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1.02 [0.9-1.14],0.799597925812841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,1.07 [0.65-1.75],0.801441457439848,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,15,1.02 [0.85-1.23],0.801694584768892,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NFASC,Neurofascin,Inverse variance weighted,6,0.94 [0.6-1.48],0.802560146052589,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,1.03 [0.82-1.3],0.804221046664704,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,1.04 [0.77-1.39],0.805103073394967,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,3,0.95 [0.61-1.47],0.805387924705771,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,9,0.95 [0.65-1.39],0.806254257537237,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KLK6,Kallikrein-6,Inverse variance weighted,2,1.05 [0.71-1.55],0.807338687686474,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.98 [0.81-1.18],0.808020776761853,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,16,1.02 [0.89-1.15],0.808619840359333,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FCN1,Ficolin-1,Inverse variance weighted,50,0.99 [0.94-1.05],0.811518499163729,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LGMN,Legumain,Inverse variance weighted,22,0.98 [0.85-1.14],0.811918119482529,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.02 [0.84-1.24],0.812254254851682,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PREB,Prolactin regulatory element-binding protein,Wald ratio,1,0.92 [0.45-1.87],0.813048160090297,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.95 [0.59-1.5],0.813360922393197,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,0.99 [0.88-1.1],0.814041636402849,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,0.97 [0.75-1.25],0.814292950475906,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RETN,Resistin,Inverse variance weighted,19,0.98 [0.84-1.15],0.817377349483967,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CTSH,Pro-cathepsin H,Inverse variance weighted,10,0.97 [0.77-1.23],0.818804965471215,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.03 [0.79-1.34],0.819927452049323,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,1.02 [0.84-1.25],0.82059870718146,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,7,1.02 [0.83-1.27],0.822796331977889,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DRAXIN,Draxin,Inverse variance weighted,25,0.99 [0.89-1.1],0.825430311850306,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,1.06 [0.65-1.7],0.82545279543709,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD27,CD27 antigen,Inverse variance weighted,9,1.03 [0.82-1.29],0.825985282491922,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,1.01 [0.92-1.12],0.826667875885948,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,WFDC1,WAP four-disulfide core domain protein 1,Wald ratio,1,1.08 [0.53-2.22],0.829393749676575,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,STC1,Stanniocalcin-1,Inverse variance weighted,9,0.98 [0.81-1.19],0.829460172710027,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.98 [0.83-1.16],0.829873294905192,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CRYBB2,Beta-crystallin B2,Inverse variance weighted,30,0.99 [0.92-1.07],0.831131228331228,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ROBO1,Roundabout homolog 1,Inverse variance weighted,18,1.02 [0.87-1.18],0.836982549129455,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,0.96 [0.65-1.42],0.837903690388353,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CHAD,Chondroadherin,Inverse variance weighted,15,1.01 [0.91-1.12],0.837996146691489,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,0.97 [0.75-1.26],0.838063948343045,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,1.08 [0.52-2.25],0.838094283928921,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,1.01 [0.93-1.09],0.838339269292548,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,31,1.01 [0.92-1.1],0.840046087205574,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,WNT9A,Protein Wnt-9a,Wald ratio,1,1.09 [0.48-2.47],0.841067176261684,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,19,1.01 [0.91-1.12],0.842419526311525,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,5,0.96 [0.65-1.43],0.843643624862171,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TMPRSS11D,Transmembrane protease serine 11D,Wald ratio,1,0.94 [0.49-1.79],0.844630065327125,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,INSR,Insulin receptor,Inverse variance weighted,5,0.97 [0.74-1.28],0.844967894881635,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,0.98 [0.83-1.16],0.844980628245437,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,F2R,Proteinase-activated receptor 1,Inverse variance weighted,6,1.02 [0.82-1.27],0.845672253731059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,XPNPEP2,Xaa-Pro aminopeptidase 2,Inverse variance weighted,20,0.99 [0.88-1.11],0.845909534513335,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,VWF,von Willebrand factor,Inverse variance weighted,6,0.98 [0.78-1.23],0.845925104940464,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,1.02 [0.83-1.26],0.846221793379864,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CST6,Cystatin-M,Inverse variance weighted,26,1.01 [0.9-1.14],0.848739838332548,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PTPRR,Receptor-type tyrosine-protein phosphatase R,Wald ratio,1,0.96 [0.61-1.5],0.849910664161357,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,0.98 [0.81-1.19],0.850028798530325,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,7,0.97 [0.68-1.37],0.852849711906357,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,19,0.99 [0.9-1.09],0.853786248278366,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,0.92 [0.39-2.18],0.854016166164017,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CBLN4,Cerebellin-4,Inverse variance weighted,17,1.01 [0.92-1.11],0.855226208606212,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.96 [0.63-1.47],0.856652801773983,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.02 [0.8-1.3],0.857168352957298,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SEZ6,Seizure protein 6 homolog,Inverse variance weighted,2,0.97 [0.66-1.41],0.857980760562973,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PGF,Placenta growth factor,Inverse variance weighted,5,0.98 [0.77-1.24],0.858411279945336,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",Inverse variance weighted,4,1.05 [0.61-1.82],0.858640475510375,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SCLY,Selenocysteine lyase,Inverse variance weighted,4,0.95 [0.55-1.64],0.858872967733536,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PGA4,Pepsin A-4,Inverse variance weighted,7,1.02 [0.82-1.28],0.858984305676643,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL19,C-C motif chemokine 19,Inverse variance weighted,4,1.03 [0.74-1.45],0.859726268190036,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.06 [0.57-1.96],0.861059474285308,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SEPTIN8,Septin-8,Inverse variance weighted,4,1.02 [0.78-1.34],0.861988344092453,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,Wald ratio,1,1.07 [0.49-2.35],0.862451687924641,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1.02 [0.81-1.28],0.864090168892489,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,0.96 [0.62-1.5],0.864990023759995,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,1.03 [0.75-1.42],0.864992784899431,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LGALS9,Galectin-9,Inverse variance weighted,36,1.01 [0.94-1.08],0.866070692847688,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,REN,Renin,Inverse variance weighted,8,1.02 [0.78-1.34],0.867847437510091,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,1 [0.94-1.05],0.869832811488795,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.04 [0.68-1.58],0.8703472328745,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,COLEC12,Collectin-12,Inverse variance weighted,3,1.04 [0.62-1.77],0.871212061304585,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,3,0.98 [0.76-1.27],0.871725557593109,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,0.98 [0.82-1.19],0.873695270313412,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RNASE10,Inactive ribonuclease-like protein 10,Wald ratio,1,1.06 [0.49-2.3],0.874745801205174,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,0.97 [0.69-1.37],0.875261351525733,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,0.96 [0.61-1.53],0.8776084019209,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD164,Sialomucin core protein 24,Inverse variance weighted,8,0.99 [0.82-1.18],0.877736643104777,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL15,Interleukin-15,Inverse variance weighted,35,0.99 [0.91-1.08],0.877933625246738,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CLGN,Calmegin,Inverse variance weighted,6,0.98 [0.8-1.21],0.878642250514124,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,1.05 [0.55-2.02],0.880394776631164,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,1.01 [0.84-1.23],0.882727081124258,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ACE,Angiotensin-converting enzyme,Inverse variance weighted,27,1 [0.94-1.06],0.883358749297466,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.98 [0.75-1.28],0.883850453188859,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,STAB2,Stabilin-2,Inverse variance weighted,14,1.01 [0.86-1.2],0.884068197131248,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KLF4,Krueppel-like factor 4,Wald ratio,1,1.08 [0.39-2.94],0.884082642116367,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HMOX2,Heme oxygenase 2,Inverse variance weighted,3,1.02 [0.76-1.37],0.886612600413322,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SSNA1,Sjoegren syndrome nuclear autoantigen 1,Wald ratio,1,1.05 [0.5-2.22],0.887754479778636,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,DLL1,Delta-like protein 1,Inverse variance weighted,6,1.02 [0.78-1.33],0.888696029960888,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,29,0.99 [0.92-1.08],0.889258224103663,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,0.96 [0.56-1.66],0.891359772374418,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1.02 [0.79-1.31],0.891487796613252,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,3,0.97 [0.61-1.55],0.892952505531653,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,OCLN,Occludin,Inverse variance weighted,2,1.07 [0.42-2.73],0.89336545574589,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,43,1 [0.96-1.05],0.894334802515528,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,1.03 [0.64-1.67],0.895511380932297,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,1.02 [0.78-1.33],0.900996368525732,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HAO1,Hydroxyacid oxidase 1,Inverse variance weighted,6,0.97 [0.61-1.54],0.90410797384068,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,17,0.99 [0.9-1.1],0.905456107312318,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FUOM,Fucose mutarotase,Inverse variance weighted,6,1.02 [0.76-1.35],0.906229000286403,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,1.01 [0.8-1.28],0.909365134657227,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,AGRP,Agouti-related protein,Inverse variance weighted,16,0.99 [0.88-1.12],0.91099809856086,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,14,1.01 [0.8-1.29],0.912552618249298,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,BCAN,Brevican core protein,Inverse variance weighted,12,0.99 [0.84-1.17],0.916120044060296,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD93,Complement component C1q receptor,Inverse variance weighted,2,1.02 [0.69-1.51],0.916377970946353,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,14,0.99 [0.78-1.24],0.916589040649067,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Wald ratio,1,0.97 [0.52-1.8],0.92190660454482,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PALM,Paralemmin-1,Inverse variance weighted,4,0.99 [0.74-1.32],0.921926277687206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,47,1 [0.93-1.08],0.924998209218939,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FAM3D,Protein FAM3D,Inverse variance weighted,38,1 [0.93-1.07],0.925054895625616,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ECHS1,"Enoyl-CoA hydratase, mitochondrial",Inverse variance weighted,5,1.01 [0.86-1.19],0.925384477770002,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FAM171B,Protein FAM171B,Inverse variance weighted,10,1.01 [0.82-1.25],0.927769703891369,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1 [0.96-1.04],0.929909034299564,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,1.02 [0.72-1.44],0.930795111072289,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,1 [0.93-1.07],0.932942558921102,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NPTX1,Neuronal pentraxin-1,Inverse variance weighted,46,1 [0.96-1.05],0.9338624377871,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,16,1.01 [0.87-1.16],0.939734216030752,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,1 [0.89-1.11],0.941644478601227,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SBSN,Suprabasin,Inverse variance weighted,10,1.01 [0.81-1.25],0.943052797609555,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,2,0.98 [0.63-1.54],0.944951455201697,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,1.02 [0.65-1.58],0.945694445042018,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,1.01 [0.83-1.22],0.946446645276137,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,1 [0.89-1.13],0.947977157674268,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CCL17,C-C motif chemokine 17,Inverse variance weighted,27,1 [0.95-1.06],0.951177659029264,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,15,1 [0.9-1.11],0.951500964854758,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,QSOX1,Sulfhydryl oxidase 1,Inverse variance weighted,7,1 [0.86-1.15],0.952216135704611,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,Inverse variance weighted,7,1 [0.87-1.14],0.953242553781778,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,0.98 [0.53-1.83],0.956191658026296,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD83,CD83 antigen,Inverse variance weighted,14,1 [0.85-1.19],0.95669702924638,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,S100G,Protein S100-G,Inverse variance weighted,4,1.01 [0.75-1.35],0.958968509610799,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CDH6,Cadherin-6,Inverse variance weighted,5,1.01 [0.75-1.35],0.958976743684642,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Wald ratio,1,0.98 [0.52-1.86],0.960346413750637,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CFD,Complement factor D,Wald ratio,1,0.98 [0.53-1.82],0.961193674178608,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,Inverse variance weighted,21,1 [0.93-1.07],0.961826519256018,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,0.99 [0.79-1.25],0.962339554607285,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,23,1 [0.93-1.07],0.962736122024816,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EPPK1,Epiplakin,Inverse variance weighted,30,1 [0.95-1.05],0.963096531982391,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.01 [0.78-1.3],0.963193126609953,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,29,1 [0.88-1.14],0.964263652156938,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.01 [0.74-1.36],0.966297132019347,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,S100P,Protein S100-P,Inverse variance weighted,4,0.99 [0.75-1.32],0.967259356689682,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,1 [0.84-1.18],0.972196750496234,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,1 [0.77-1.29],0.972610330434353,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,PCDH17,Protocadherin-17,Inverse variance weighted,44,1 [0.95-1.05],0.976938822395949,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,1 [0.76-1.3],0.97884258870944,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",Wald ratio,1,1.01 [0.59-1.73],0.979637530497052,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,TRIAP1,TP53-regulated inhibitor of apoptosis 1,Inverse variance weighted,9,1 [0.79-1.25],0.980501565927456,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,6,1 [0.85-1.19],0.982453614192183,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,EPO,Erythropoietin,Inverse variance weighted,11,1 [0.89-1.12],0.985265038968889,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,1 [0.88-1.14],0.988431948276978,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,AGRN,Agrin,Inverse variance weighted,14,1 [0.86-1.16],0.989405542265019,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,1 [0.54-1.87],0.991043999144661,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1 [0.79-1.26],0.992415892015731,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1 [0.76-1.32],0.994438276182692,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,LEPR,Leptin receptor,Inverse variance weighted,3,1 [0.63-1.58],0.997498150286987,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,IL19,Interleukin-19,Inverse variance weighted,10,1 [0.92-1.09],0.999109016565887,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,CA4,Carbonic anhydrase 4,Inverse variance weighted,25,1 [0.93-1.07],0.999977920023691,trans
